Skip to main content
[vc_row type=”full_width_background” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_image=”62770″ bg_position=”right center” background_image_loading=”default” bg_repeat=”no-repeat” full_height=”yes” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” enable_gradient=”true” color_overlay=”#ffffff” color_overlay_2=”rgba(255,255,255,0.01)” overlay_strength=”0.8″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”zoom-out-slow” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”2/5″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text css_animation=”fadeIn”]

Blogs

[/vc_column_text][/vc_column][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”3/5″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][nectar_global_section id=”44″][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” top_padding=”50″ bottom_padding=”50″ text_color=”dark” text_align=”center” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” disable_element=”yes” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_raw_html]JTNDZm9ybSUyMGlkJTNEJTIybmV3cy1mb3JtJTIyJTNFJTBBJTNDaW5wdXQlMjBpZCUzRCUyMnNlYXJjaC10ZXh0JTIyJTIwbmFtZSUzRCUyMnMlMjIlMjB0eXBlJTNEJTIydGV4dCUyMiUyMHBsYWNlaG9sZGVyJTNEJTIyU2VhcmNoJTIwYXJ0aWNsZXMlMjIlMkYlM0UlMEElM0MlMkZmb3JtJTNF[/vc_raw_html][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][divider line_type=”No Line” custom_height=”80″][nectar_post_grid post_type=”post” blog_category=”blog” order=”DESC” orderby=”date” pagination=”load-more” button_color=”black” columns=”3″ grid_item_spacing=”15px” grid_item_height=”40vh” enable_sortable=”yes” sortable_alignment=”default” sortable_color=”default” enable_masonry=”yes” image_size=”large” aspect_ratio_image_size=”yes” custom_image_aspect_ratio=”4-3″ image_loading=”lazy-load” animation=”fade-in-from-bottom” heading_tag=”default” category_position=”default” display_date=”yes” grid_style=”content_under_image” card_design=”yes” card_bg_color=”#f7f7f7″ content_under_image_text_align=”left” text_color=”dark” hover_effect=”zoom” border_radius=”5px” shadow_on_hover=”yes”][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” disable_element=”yes” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]

How Wearable ECG Technology Is Transforming Heart Care

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Wearable Ecg Technology Is Transforming Heart Care

How Compact ECG Devices Improve Patient Compliance and Data Accuracy

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Compact Ecg Devices Improve Patient Compliance And Data Accuracy

Holter Monitor vs. Continuous Patch ECG: What’s the Clinical Difference?

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Holter Monitor Vs Continuous Patch Ecg Whats The Clinical Difference

Early Detection of Cardiac Arrhythmias Using Continuous ECG Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Early Detection Of Cardiac Arrhythmias Using Continuous Ecg Monitoring

Why Continuous Cardiac Monitoring with Mobile Cardiac Telemetry Is Replacing Traditional Holter Testing

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Wireless Heart Monitor Is Replacing Holter

Discover The Top Trends Shaping Digital Cardiology

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Discover The Top Trends Shaping Digital Cardiology

Early Detection with Cardiac Monitor Patch Devices

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Early Detection Saves Lives

The Best Heart Monitor: The Shift From Devices Toward Integrated Digital Ecosystems

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Best Heart Monitor

The Future of Wearable Health Technology in Chronic Disease Management

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Future Of Wearable Health Technology

How Remote Cardiac Monitoring is Expected to Evolve

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Remote Cardiac Monitoring

Biotricity delivers strong Q3 Fiscal 2026 performance, growing revenue momentum and expanding EBITDA

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Delivers Strong Q3 Fiscal 2026 Performance Growing Revenue Momentum And Expanding Ebitda

Biotricity to announce continued growth in fiscal 2026 third quarter financial results and business update call on February 11th

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Announce Continued Growth In Fiscal 2026 Third Quarter Financial Results And Business Update Call On February 11th

Understanding EKG Heart Rhythms and What They Reveal About Your Health

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Ekg Heart Rhythms And What They Reveal About Your Health

Beyond the Beat: How Biotricity’s Biocore Pro Outperforms Other Heart Monitors

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Beyond The Beat How Biotricitys Biocore Pro Outperforms Other Heart Monitors

How Biotricity Is Transforming the Future of Cardiovascular Tests

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Biotricity Is Transforming The Future Of Cardiovascular Tests

Why Biotricity Leads the Heart Monitoring Revolution: Smarter, Faster, and More Reliable Than the Rest

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Biotricity Leads The Heart Monitoring Revolution Smarter Faster And More Reliable Than The Rest

Biotricity strengthens path to scalable profitability for second quarter Fiscal 2026 with sustained margins & operational efficiency

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Strengthens Path To Scalable Profitability For Second Quarter Fiscal 2026 With Sustained Margins Operational Efficiency

Biotricity to host Fiscal 2026 second quarter financial results and business update call on November 14th

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Host Fiscal 2026 Second Quarter Financial Results And Business Update Call On November 14th

Spider Heart Monitor vs. Biotricity’s Biocore Pro: Choosing for Your Cardiac Monitoring Needs?

Heart disease is the leading cause of death globally and effective heart monitoring is essential to ensure that any potential issues are detected promptly and reliably. Thanks to advancements in…

Read Moreabout Spider Heart Monitor Vs Biotricitys Biocoke Pro

Why Buying Medical Devices Directly from the Manufacturer Is the Smarter Choice

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Buying Medical Devices Manufacturer Versus Distributor

What Is a Cardiac Patch Monitor? Your Guide to Monitoring with a Heart Patch Monitor

Keeping an eye on your heart health used to mean long waits at the clinic, dealing with insurance approvals, and being hooked up to wires and bulky machines—even for monitoring…

Read Moreabout Cardiac Monitor Patch Guide

Wireless 30-Day Heart Monitor: Track Your Heart Health with Ease

Ever feel your heart skip a beat or race out of nowhere and wonder if it’s something serious? You’re not alone. These kinds of sensations are more common than most…

Read Moreabout Wireless 30 Day Heart Monitor Track Your Heart Health With Ease

Monitor Your Heart Using a Cardiac Monitor Patch

Ever had a strange flutter in your chest and wondered if it meant something serious? You’re not alone. Many heart symptoms are intermittent, appearing and disappearing without warning. Some people…

Read Moreabout Monitor Your Heart Using A Cardiac Monitor Patch

Biotricity’s Biokit: A Smarter Way to Manage Blood Pressure and Heart Rate at Home

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricitys Biokit A Smarter Way To Manage Blood Pressure And Heart Rate At Home

Biotricity recognized by Financial Times as one of 2025’s fastest-growing companies in the Americas, growing 256.4% over the period analyzed

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Recognized By Financial Times As One Of 2025s Fastest Growing Companies In The Americas Growing 256 4 Over The Period Analyzed

Transforming Heart Health: Why Biotricity Is the Future of Cardiac Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Revolutionizing Cardiac Monitoring

Revolutionizing Cardiac Monitoring with Biotricity’s Advanced ePatch Monitor, Biocore Pro

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Future Of Cardiac Care With Biotricity

Quick Guide to Advancements in Remote Cardiac Monitoring & the Future of Cardiac Care with Biotricity

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Revolutionizing Remote Cardiac Monitoring

Real-Time Heart Monitoring: Empowering Patients with Data

Heart disease remains a critical global health challenge. Cardiovascular diseases (CVDs) affect more than half a billion people worldwide and were responsible for nearly one-third of all global deaths in…

Read Moreabout Real Time Heart Monitoring Empowering Patients With Data

Biotricity: Pioneering the Future of Cardiac Health with Heart Monitor Patches

Heart disease is the leading cause of death for men and women in the U.S., with at least one person dying as a result of cardiovascular disease (CVD) every 33…

Read Moreabout Biotricity Pioneering The Future Of Cardiac Health With Heart Monitor Patches

The Convenience and Accuracy of a Wireless 30-Day Heart Monitor

When it comes to heart health, staying informed about your heart’s activity isn’t just a smart decision—it could be lifesaving. Advances in heart health care have made it possible to…

Read Moreabout The Convenience And Accuracy Of A Wireless 30 Day Heart Monitor

Biotricity’s Wearable Heart Monitor – A Smarter Way to Manage Heart Health

Heart disease remains the leading cause of death in the world. Because of the complexity of the disease, managing it can often feel overwhelming. Patients juggle doctor appointments, tests, and…

Read Moreabout Biotricitys Wearable Heart Monitor A Smarter Way To Manage Heart Health

How Monitoring Medical Devices Are Transforming Patient Home Monitoring?

Imagine a patient recovering from heart surgery or managing a chronic condition like diabetes, adjusting their lifestyle to manage medications and blood sugar levels. For decades, these patients’ care relied…

Read Moreabout How Monitoring Medical Devices Are Transforming Patient Home Monitoring

Biotricity expands IP portfolio & strategy with 14 new patents, reinforcing innovation & leadership in remote monitoring, diagnostics, & chronic disease management

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Expands Ip Portfolio Strategy With 14 New Patents Reinforcing Innovation Leadership In Remote Monitoring Diagnostics Chronic Disease Management

Heart Health Made Easy – Exploring Biotricity’s Innovative Remote Monitoring Solutions

90% of U.S. adults are at risk of developing cardiovascular disease, yet 80% of premature cardiovascular diseases are preventable with early intervention.  Biotricity’s remote cardiac monitoring solutions are bringing us…

Read Moreabout Remote Monitoring Solutions For Heart Health

Revolutionizing Cardiac Care: How Biotricity’s Technology Empowers Patients and Physicians

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Revolutionizing Cardiac Car With Biotricitys

Why Remote Health Monitoring is the Future – A Deep Dive into Biotricity’s Impact on Cardiac Care

Heart disease is difficult to diagnose because its symptoms can occur intermittently, and in many cases, patients may not experience any symptoms, especially in the early stages. The unpredictable nature…

Read Moreabout Remote Health Monitoring Is The Future

Biotricity delivers record margins, record revenues, and record cashflows with 21.7% year-over-year sales growth for its third quarter of fiscal 2025

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Delivers Record Margins Record Revenues And Record Cashflows With 21 7 Year Over Year Sales Growth For Its Third Quarter Of Fiscal 2025

Understanding Heart Health: Recognizing the Signs in Women

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Heart Health Recognizing The Signs In Women

The Connection Between Heart and Kidney Health: Why It Matters

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Connection Between Heart Kidney Health Why It Matters

Understanding Asthma: Types, Triggers, and Management

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Asthma Types Triggers Management

The Future of Heart Health: Innovation in Home-Based Health Screening

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Future Of Heart Health Innovation In Home Based Health Screening

Comprehensive Heart Screenings: The Key to Understanding Your Cardiovascular Health

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Comprehensive Heart Screenings The Key To Understanding Your Cardiovascular Health

The Importance of Long-Term ECG Heart Monitoring: Beyond the Basics

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Importance Of Long Term Ecg Heart Monitoring Beyond The Basics

Advancing Cardiac Care with Rhythm Heart Monitor Technologies

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Advancing Cardiac Care With Rhythm Heart Monitor Technologies

Revolutionizing Heart Health Monitoring with Advanced Mini Heart Monitor and ePatch Devices

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Revolutionizing Heart Health Monitoring With Advanced Mini Heart Monitor And Epatch Devices

Beyond Wearables: The Importance of A Routine Comprehensive Heart Test for Asymptomatic Individuals

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Beyond Wearables

The Importance Managing High Cholesterol and Routine Heart Health Tests

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Importance Managing High Cholesterol And Routine Heart Health Tests

The Impact of Genetic Testing on Cardiovascular Health

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Impact Of Genetic Testing On Cardiovascular Health

The Importance of Routine Blood Sugar Testing and Heart Screenings for Diabetes Patients

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Importance Of Routine Blood Sugar Testing And Heart Screenings For Diabetes Patients

Biotricity and B-Secur partner to launch the most comprehensive device-neutral ambulatory cardiac monitoring platform

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity And B Secur Partner To Launch The Most Comprehensive Device Neutral Ambulatory Cardiac Monitoring Platform

How Biotricity’s Remote Cardiac Monitor is Revolutionizing Heart Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Biotricitys Remote Cardiac Monitor Is Revolutionizing Heart Monitoring

Why Biotricity is the Leading Choice Among Heart Monitor Companies

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Biotricity Is The Leading Choice Among Heart Monitor Companies

Why Biotricity is the Leading Heart Monitoring Company in the Industry

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Top Holter Monitor Company In The Industry

Shaping the Future of Heart Health with the Remote ECG and Heart Rate Monitor PatchRX-1 Mini, RX-1 Mini Heart Monitor, Spider Heart Monitor, Butterfly Heart Monitor, VitalConnect Cardiac Monitoring, VitalConnect Cardiac Monitor

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Shaping The Future Of Heart Health With The Remote Ecg And Heart Rate Monitor Patch

How The Small Heart Monitor and Mini EKG Are Revolutionizing Cardiac Care

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How The Small Heart Monitor And Mini Ekg Are Revolutionizing Cardiac Care

Biotricity produces largest inventory in its history to meet accelerated demand

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Produces Largest Inventory In Its History To Meet Accelerated Demand

How Biotricity is Paving the Way for Personalized Cardiac Care with it’s Remote Cardiac Monitor

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Biotricity Is Paving The Way For Personalized Cardiac Care With Its Remote Cardiac Monitor

How Biotricity Helps Patients Take Control of Their Heart Health with Remote Vital Sign Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Biotricity Helps Patients Take Control Of Their Heart Health With Remote Vital Sign Monitoring

Why Remote Biometric Monitoring is Revolutionizing Diagnostics and Treatment

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Remote Biometric Monitoring Is Revolutionizing Diagnostics And Treatment

Biotricity achieves positive free cash flow milestone

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Achieves Positive Free Cash Flow Milestone

The Future of Digital Health: Explore Biotricity’s Cutting-Edge Solutions

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Future Of Digital Health Explore Biotricitys Cutting Edge Solutions

Biotricity: Transforming Healthcare Through Innovation and Connection

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Transforming Healthcare Through Innovation And Connection

Empowering Heart Health with Biotricity’s Advanced Monitoring Solutions

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Empowering Heart Health With Biotricitys Advanced Monitoring Solutions

The Evolution of Remote Cardiac Monitoring: The Future of Heart Health Management

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Evolution Of Remote Cardiac Monitoring The Future Of Heart Health Management

Understanding Heart Rate Variability: What It Means for Your Health

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Heart Rate Variability What It Means For Your Health

The Future of Wearable Heart Monitors: Compact, Comfortable, and Connected

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Future Of Wearable Heart Monitors Compact Comfortable And Connected

The Evolution of Remote Vital Sign Monitoring: A Comprehensive Overview

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Evolution Of Remote Vital Sign Monitoring For Continuous Patient Monitoring In Healthcare

Biotricity achieves improved margins and efficiencies, and year-over-year sales growth for second quarter of fiscal year 2025

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Achieves Improved Margins And Efficiencies And Year Over Year Sales Growth For Second Quarter Of Fiscal Year 2025

Choosing the Right External Cardiac Monitor for Remote ECG Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Choosing The Right External Cardiac Monitor For Remote Ecg Monitoring

Why Remote Cardiac Monitoring Devices are Essential for Early Diagnosis

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Remote Cardiac Monitoring Devices Are Essential For Early Diagnosis

How Continuous Data Access is Revolutionizing Cardiology Patient Care

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Continuous Data Access Is Revolutionizing Cardiology Patient Care

Innovations in Continuous Ambulatory Cardiac Monitoring: What Sets Biotricity Apart?

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Heart Disease Curreninnovations In Continuous Ambulatory Cardiac Monitoring What Sets Biotricity Apartt Guidelines And The Role Of Advanced Monitoring Solutions 2

Understanding Heart Disease: Current Guidelines and the Role of Advanced Monitoring Solutions

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Understanding Heart Disease Current Guidelines And The Role Of Advanced Monitoring Solutions

Top 5 Benefits of Using a Continuous Portable ECG Monitor for Heart Health

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Top 5 Benefits Of Using A Continuous Portable Ecg Monitor For Heart Health

Why Early Detection of Arrhythmia is Critical: How Biotricity’s Cardiac Solutions Help

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Why Early Detection Of Arrhythmia Is Critical How Biotricitys Cardiac Solutions Help

How Biotricity’s FDA-Approved Cardiac Monitoring Devices Improve Patient Safety

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout How Biotricitys Fda Approved Cardiac Monitoring Devices Improve Patient Safety

Heart Monitors with Built-In Cellular Technology vs. Cellphone-Dependent Devices: Enhancing Patient Safety and Cardiac Diagnostics

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Cardiac Monitoring Cellular Vs Mobile Devices

Cardiac Outpatient Monitoring: The Future of Heart Monitoring

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Cardiac Outpatient Monitoring The Future Of Heart Monitoring

A Comprehensive Guide to Ambulatory Monitoring: What You Need to Know

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout A Comprehensive Guide To Ambulatory Monitoring What You Need To Know

The Future of Cardiac Monitoring: How Smart Monitoring Wireless Solutions are Transforming Heart HealthCare Delivery for Cardiac Patients  

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Https Biotricity Com Blogs Heart Monitors With Built In Cellular Technology Vs Cellphone Dependent Devices

The Evolution of Cardiac Monitoring: From Wired Devices to Wireless Patch Monitors

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Shift From Wired Holter Monitors To Wireless Cardiac Monitors A New Era Of Cardiac Care

Holter Monitoring vs. Cardiac Outpatient Monitoring: Which is Right for You?

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Holter Monitoring Vs Cardiac Outpatient Monitoring Which Is Right For You

The Shift from Wired Holter Monitors to Wireless Cardiac Monitors: A New Era of Cardiac Care

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout The Evolution Of Cardiac Monitoring From Wired Devices To Wireless Patch Monitors

Biotricity provides updated guidance for earlier than expected path to profitability due to growing revenues and improving margins

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Provides Updated Guidance For Earlier Than Expected Path To Profitability Due To Growing Revenues And Improving Margins

Biotricity announces inclusion as a supplier to a prominent medical system that services 21 states

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces Inclusion As A Supplier To A Prominent Medical System That Services 21 States

Biotricity kicks off another pilot program with a major hospital system that services over 800K individuals

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Kicks Off Another Pilot Program With A Major Hospital System That Services Over 800k Individuals

Biotricity reports continued margin improvement and reduced losses in its first quarter fiscal year 2025

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Reports Continued Margin Improvement And Reduced Losses In Its First Quarter Fiscal Year 2025

Biotricity announces continued margin improvement driven by its proprietary AI cloud

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces Continued Margin Improvement Driven By Its Proprietary Ai Cloud

Biotricity announces accelerated path to EBITDA Positive

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces Accelerated Path To Ebitda Positive

Biotricity adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Adds 60 Site Multi State Hospital Cardiac Monitoring Pilot Program

Biotricity launches Direct-to-Consumer heart health screening service, HeartSecure, making heart health services accessible in response to the #1 global killer, poising company to access the growing home diagnostics market

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Launches Direct To Consumer Heart Health Screening Service Heartsecure Making Heart Health Services Accessible In Response To The 1 Global Killer Poising Company To Access The Growing H

Biotricity provides year-end guidance with expectations to meet analyst revenue target and beating loss and margin targets

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Provides Year End Guidance With Expectations To Meet Analyst Revenue Target And Beating Loss And Margin Targets

Biotricity preferred shareholders show increased commitment and support of the company by converting almost all Preferred A shares into Restricted Common Stock

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Preferred Shareholders Show Increased Commitment And Support Of The Company By Converting Almost All Preferred A Shares Into Restricted Common Stock

Biotricity announces the upcoming launch of the first-ever direct-to-patient cardiac screening service, targeting the $1.05B home heart health market

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces The Upcoming Launch Of The First Ever Direct To Patient Cardiac Screening Service Targeting The 1 05b Home Heart Health Market

Biotricity expands market reach to pulmonary and neurology fields through latest partnerships with two leading home-based diagnostic companies

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Bbiotricity Expands Market Reach To Pulmonary And Neurology Fields Through Latest Partnerships With Two Leading Home Based Diagnostic Companies

Biotricity’s path towards breakeven accelerated by latest diagnostic product, Biotres Pro, garnering rapid interest from existing and new customers

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricitys Path Towards Breakeven Accelerated By Latest Diagnostic Product Biotres Pro Garnering Rapid Interest From Existing And New Customers

Biotricity launches major cardiac monitoring pilot program in a hospital system comprised of 9 hospitals and 10 clinics

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Launches Major Cardiac Monitoring Pilot Program In A Hospital System Comprised Of 9 Hospitals And 10 Clinics

Biotricity launches cardiac monitoring pilot program with major hospital network

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Launches Cardiac Monitoring Pilot Program With Major Hospital Network

Biotricity announces a strategic partnership for cardiac screenings in patients with co-morbidities

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces A Strategic Partnership For Cardiac Screenings In Patients With Co Morbidities

Biotricity accelerates market access by partnering with third major group purchasing organization, expanding market reach to 90% of U.S. hospitals

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Accelerates Market Access By Partnering With Third Major Group Purchasing Organization Expanding Market Reach To 90 Of U S Hospitals

Biotricity partners with Health Aid Africa to provide complementary heart health screenings at Allegiant Stadium Concert

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Partners With Health Aid Africa To Provide Complementary Heart Health Screenings At Allegiant Stadium Concert

Biotricity unveils that improved margins resulted from latest advancements to its proprietary cardiac AI cloud platform and announces plans for continued expansion of its cardiac AI cloud

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Unveils That Improved Margins Resulted From Latest Advancements To Its Proprietary Cardiac Ai Cloud Platform And Announces Plans For Continued Expansion Of Its Cardiac Ai Cloud

Biotricity partners with a second top group purchasing organization – positions company for expanded market access to 1 out of every 2 hospitals in America

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Partners With A Second Top Group Purchasing Organization Positions Company For Expanded Market Access To 1 Out Of Every 2 Hospitals In America

Biotricity receives Health Canada clearance for Biotres

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Receives Health Canada Clearance For Biotres

Biotricity strengthens its foundation for growth, achieves lower cost of sales, expanding margins of 73% and increased device sales, for third quarter of Fiscal Year 2024

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Strengthens Its Foundation For Growth Achieves Lower Cost Of Sales Expanding Margins Of 73 And Increased Device Sales For Third Quarter Of Fiscal Year 2024

Biotricity to host third quarter Fiscal Year 2024 financial results and business update call on February 21st

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Host Third Quarter Fiscal Year 2024 Financial Results And Business Update Call On February 21st

Biotricity advances towards breakeven milestone – set to announce record margins and operational efficiency for third quarter of Fiscal Year 2024

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Advances Towards Breakeven Milestone Set To Announce Record Margins And Operational Efficiency For Third Quarter Of Fiscal Year 2024

Biotricity expands development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Expands Development Of Its Cardiac Ai Cloud Platform With Data Ecosystem Of Over 360 Billion Heartbeats

Biotricity delivers record margins and double digit year-over-year sales growth for second quarter of fiscal year 2024

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Delivers Record Margins And Double Digit Year Over Year Sales Growth For Second Quarter Of Fiscal Year 2024

Biotricity to host second quarter fiscal year 2024 financial results and business update call on November 14th

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Host Second Quarter Fiscal Year 2024 Financial Results And Business Update Call On November 14th

Biotricity releases another groundbreaking product: Biotres Pro

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Releases Another Groundbreaking Product Biotres Pro

Biotricity continues to expand patent portfolio with latest patent filing for Bioheart device

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Continues To Expand Patent Portfolio With Latest Patent Filing For Bioheart Device

CORRECTION BY SOURCE: Biotricity announces patent filing for cutting-edge Biotres device

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Correction By Source Biotricity Announces Patent Filing For Cutting Edge Biotres Device

Biotricity announces patient filing for cutting-edge Biotres device

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces Patient Filing For Cutting Edge Biotres Device

Biotricity unveils a new digital presence, highlighting its expanding technology portfolio and cutting-edge innovations

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Unveils A New Digital Presence Highlighting Its Expanding Technology Portfolio And Cutting Edge Innovations

Biotricity achieves $14 Million Revenue Run Rate in August 2023

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Achieves 14 Million Revenue Run Rate In August 2023

Biotricity reports strong growth for its first quarter fiscal year 2024 and provides financial results and business updates

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Reports Strong Growth For Its First Quarter Fiscal Year 2024 And Provides Financial Results And Business Updates

Biotricity to host first quarter Fiscal Year 2024 financial results and business update call on August 15th

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Host First Quarter Fiscal Year 2024 Financial Results And Business Update Call On August 15th

Biotricity shows continued growth and strength in its fundamentals on its path to profitability

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Shows Continued Growth And Strength In Its Fundamentals On Its Path To Profitability

Biotricity expands its proprietary AI model and deepens relationship with Amazon AWS and Google’s tensor flow for remote cardiac care applications

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Expands Its Proprietary Ai Model And Deepens Relationship With Amazon Aws And Googles Tensor Flow For Remote Cardiac Care Applications

Biotricity regains Nasdaq listing compliance

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Regains Nasdaq Listing Compliance

Biotricity reports strong start to fiscal year 2024

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Reports Strong Start To Fiscal Year 2024

Biotricity announces reverse stock split

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Announces Reverse Stock Split

Biotricity to host Fiscal Year 2023 financial results and business update call on June 30th

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity To Host Fiscal Year 2023 Financial Results And Business Update Call On June 30th

Biotricity CEO speaks to the future of AI and its contributions to healthcare

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Ceo Speaks To The Future Of Ai And Its Contributions To Healthcare

Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Reaches 13m Revenue Run Rate In April 2023 On Accelerating Growth

Biotricity’s founder & CEO Waqaas Al-Siddiq to present at World Heart Summit May 19-21 in Geneva, Switzerland

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricitys Founder Ceo Waqaas Al Siddiq To Present At World Heart Summit May 19 21 In Geneva Switzerland

Biotricity reaches $12M revenue run rate in March with promising future growth ahead

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Biotricity Reaches 12m Revenue Run Rate In March With Promising Future Growth Ahead

Leading medical biometric firm Biotricity releases first corporate impact report

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…

Read Moreabout Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report 2

Medical biometric firm Biotricity reshaping market through pioneering innovation

REDWOOD CITY, Calif., Mar 07, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, has not only been establishing a significant market footprint through its robust revenue growth but also reshaping its marketplace through continuous pioneering innovation. Today, Biotricity highlighted several of its major operating achievements since fiscal year 2022.

Read Moreabout Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation

Biotricity reports financial results for Fiscal 2023 Third Quarter

REDWOOD CITY, Calif., Feb 14, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced its financial results and provided a business update for its third quarter of fiscal 2023 ended December 31, 2022.

Read Moreabout Biotricity Reports Financial Results For Fiscal 2023 Third Quarter

Biotricity To host Fiscal 2023 Third Quarter Financial Results call on February 14th at 4:30pm ET

REDWOOD CITY, Calif., Feb 09, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Tuesday, February 14th, 2023 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 third quarter.

Read Moreabout Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call On February 14th At 430pm Et

Biotricity selected to present its work on AI enabled stroke prediction in CKD patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference

REDWOOD CITY, Calif., Feb 03, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is excited to announce that it is one of only eight companies selected to present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference (ISC), being held in Dallas, TX. The showcase is being co-hosted by ISC in collaboration with both the National Heart, Lung, and Blood Institute and the National Institute for Neurological Disorders and Stroke (NINDS).

Read Moreabout Biotricity Selected To Present Its Work On Ai Enabled Stroke Prediction In Ckd Patients At The 2nd Annual Innovation Showcase During The American Stroke Association 2023 International Stroke Conferenc

Biotricity signs distribution agreement with top 5 distributor for its Cardiac Monitoring Solutions

REDWOOD CITY, Calif., Jan 26, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists’ patient use – Bioflux® and BiotresTM.

Read Moreabout Biotricity Signs Distribution Agreement With Top 5 Distributor For Its Cardiac Monitoring Solutions

Biotricity to participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET

REDWOOD CITY, Calif., Jan 23, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 8:15 a.m. ET.

Read Moreabout Biotricity To Participate In The Healthcare It Virtual Conference Presented By Maxim Group Llc And Hosted By M Vest On Wednesday January 25th At 815 A M Et

Biotricity signs with top 5 group purchasing organization; potential for higher sales volume in 2023

REDWOOD CITY, Calif., Jan 17, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group purchasing organization (“GPO”) for national distribution of its cardiac monitoring solutions, Bioflux® and BiotresTM.

Read Moreabout Biotricity Signs With Top 5 Group Purchasing Organization Potential For Higher Sales Volume In 2023

Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth

REDWOOD CITY, Calif., Dec 12, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.

Read Moreabout Fda 510k

Biotricity surpasses $10 million in annual revenue run rate

REDWOOD CITY, Calif., Nov 21, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it has surpassed $10 million in annual revenue run rate.

Read Moreabout Biotricity Surpasses 10 Million In Annual Revenue Run Rate

Biotricity provides updates on its operational and expansion strategy

REDWOOD CITY, Calif., Nov 18, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, provided a recap of its recent operational and corporate activities and discussed the Company’s distribution strategy for the second half of FY 2023 ending March 31, 2023.

Read Moreabout Biotricity Provides Updates On Its Operational And Expansion Strategy

Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions

REDWOOD CITY, Calif., Nov 16, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, has signed a distribution agreement with one of the Top 10 US medical device distributors . to distribute its cardiac monitoring solutions, Bioflux and Biotres.

Read Moreabout Biotricity Signs Distribution Agreement To Expand Access For Its Cardiac Monitoring Solutions

Biotricity reports financial results for Fiscal 2023 Second Quarter

REDWOOD CITY, Calif., Nov 14, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced its financial results and provided a business update for its fiscal 2023 second quarter ended September 30, 2022.

Read Moreabout Biotricity Reports Financial Results For Fiscal 2023 Second Quarter

Biotricity’s Bioheart named to TIME’s list of The Best Inventions of 2022

REDWOOD CITY, Calif., Nov 10, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that its Bioheart device has been named to TIME’s list of the Best Inventions of 2022. Bioheart is the first of its kind – a continuous heart rhythm monitor using advanced technology to deliver unlimited heart data insights.

Read Moreabout Biotricitys Bioheart Named To Times List Of The Best Inventions Of 2022

Biotricity to host Fiscal 2023 Second Quarter financial results on November 14th at 4:30 PM ET

REDWOOD CITY, Calif., Nov 01, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.

Read Moreabout Biotricity To Host Fiscal 2023 Second Quarter Financial Results On November 14th At 430 Pm Et

Biotricity launches Cardiac Disease Management Solution following 2 successful pilots with Oklahoma & Kentucky Clinics

REDWOOD CITY, Calif., Oct 26, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac. The national roll-out follows two successful pilot programs in Oklahoma City with CardioVascular Health Clinic, a medical facility providing high-quality cardiovascular care to more than 40,000 patients, and a four-month pilot with Lexington Heart Specialists in Kentucky, a medical practice providing high-quality cardiovascular care to more than 20,000 patients.

Read Moreabout Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots With Oklahoma Kentucky Clinics

Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th

REDWOOD CITY, Calif., Oct 11, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois.

Read Moreabout Biotricity Ceo Waqaas Al Siddiq To Participate In Panel Discussion On The Evolution Of Medical Devices At The American Medical Device Summit On October 19th

Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib)

REDWOOD CITY, Calif., Oct 04, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke.

Read Moreabout Biotricity Surpasses 2 Billion Recorded And Analyzed Heartbeats For Atrial Fibrillation Afib

Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure

REDWOOD CITY, Calif., Sep 07, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease (‘CKD’).

Read Moreabout Biotricity Wins Nih Grant From The National Heart Blood And Lung Institute For Ai Enabled Real Time Monitoring And Predictive Analytics For Stroke Due To Chronic Kidney Failure

Biotricity to host Fiscal First Quarter 2023 financial results conference call on August 15th at 4:30 p.m. ET

REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call and webcast on Monday, August 15, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal first quarter 2023 and provide a business update.

Read Moreabout Biotricity To Host Fiscal First Quarter 2023 Financial Results Conference Call On August 15th At 430 P M Et

Biotricity reports financial results for Fiscal 2022 fourth quarter and full year

REDWOOD CITY, Calif., Jul 14, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced its financial results for its fiscal 2022 fourth quarter and year ended March 31, 2022.

Read Moreabout Biotricity Reports Financial Results For Fiscal 2022 Fourth Quarter And Full Year

Biotricity to join Russell Microcap(R) Index

REDWOOD CITY, Calif., Jun 23, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that the Company is expected to join the Russell Microcap® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2022.

Read Moreabout Biotricity To Join Russell Microcapr Index

Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is scheduled to present and will be participating in a fireside chat at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022. The conference will be hybrid, offering both virtual and in-person presentations at the Fontainebleau Miami Beach Hotel.

Read Moreabout Biotricity To Present At The 2022 H C Wainwright Global Investment Conference On Tuesday May 24th

Biotricity issues shareholder update

REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today provided an update for its shareholders by Chief Executive Officer Waqaas Al-Siddiq, Ph.D., that discusses recent Company achievements and strategic initiatives to position the business for strong 2022 results, increasing scale and accelerating growth into 2023.

Read Moreabout Biotricity Issues Shareholder Update

Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022

REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022. The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since late-February 2022.

Read Moreabout Biotricity To Launch Commercial Sales Of Its Disruptive Cardiac Monitoring Device Biotres In April 2022

Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022

REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Biotricity was also highlighted as #1 in this year’s Medical Devices category.

Read Moreabout Biotricity Named To Fast Companys Annual List Of The Worlds 50 Most Innovative Companies For 2022

Biotricity, Inc. to attend 34th annual Roth Conference March 13th-15th

REDWOOD CITY, Calif., Mar 04, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will attend the 34th Annual Roth Conference, being held on March 13-15, 2022 at The Ritz Carlton, Laguna Niguel in Dana Point, California.

Read Moreabout Biotricity Inc To Attend 34th Annual Roth Conference March 13th 15th

Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device

REDWOOD CITY, Calif., Feb 23, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it is now taking pre-orders for Biotres, the Company’s three-lead device designed to continuously record electro-cardiogram (ECG) data for early detection of cardiac arrhythmias.

Read Moreabout Biotricity Now Taking Pre Orders For Its Biotres Wireless Wearable Cardiac Monitoring Device

Biotricity releases Fiscal 2022 third quarter financial results

REDWOOD CITY, Calif., Feb 14, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced financial results for its 2022 fiscal year’s third quarter ended December 31, 2021.

Read Moreabout Biotricity Releases Fiscal 2022 Third Quarter Financial Results

Biotricity to report third quarter fiscal 2022 financial results on February 14, 2022

REDWOOD CITY, Calif., Feb 08, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, announced that it will release its financial results for the third quarter of fiscal 2022, ended December 31, 2021, on Monday, February 14, 2022, after the close of the market. Additionally, management will host a conference call and live webcast on Tuesday, February 15, 2022 at 4:15 p.m. EST to discuss the Company’s financial results.

Read Moreabout Biotricity To Report Third Quarter Fiscal 2022 Financial Results On February 14 2022

Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device

REDWOOD CITY, Calif., Jan 24, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today reported it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.

Read Moreabout Biotricity Receives Fda 510k Clearance For Its Biotres Cardiac Monitoring Device

Biotricity expands distribution of new Bioheart device on Amazon.com

REDWOOD CITY, Calif., Dec 28, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions, today announced it has expanded the distribution of its new Bioheart heart monitor system, a direct-to-consumer device that offers the same continuous heart monitoring technology used by physicians, on Amazon.com.

Read Moreabout Biotricity Expands Distribution Of New Bioheart Device On Amazon Com

Biotricity completes $12 million non-dilutive debt financing

REDWOOD CITY, Calif., Dec 27, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions, today announced the successful completion of a $12 million non-convertible debt financing.

Read Moreabout Biotricity Completes 12 Million Non Dilutive Debt Financing

Biotricity, a leader in remote cardiac health monitoring solutions, issues company roadmap in 2021 shareholder letter

REDWOOD CITY, Calif., Dec 07, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, has released its December 2021 CEO Shareholder Letter, which discusses recent Company milestones achieved including its financial performance, commercialization of its new Biokit, and other state-of-the-art remote cardiac monitoring devices and software apps in development.

Read Moreabout Biotricity A Leader In Remote Cardiac Health Monitoring Solutions Issues Company Roadmap In 2021 Shareholder Letter

Biotricity delivers Bioheart, a groundbreaking consumer Heart Monitor

REDWOOD CITY, Calif., Nov 10, 2021 (BUSINESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology used by physicians. Showcased in prototype form at CES 2020, Bioheart has shipped to preorder customers and is now available for purchase at www.bioheart.com.

Read Moreabout Biotricity Delivers Bioheart A Groundbreaking Consumer Heart Monitor

Biotricity releases fiscal 2022 second quarter financial results

REDWOOD CITY, Calif., Nov 04, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced financial results for its 2022 fiscal year’s second quarter ended September 30, 2021.

Read Moreabout Biotricity Releases Fiscal 2022 Second Quarter Financial Results

Biotricity to report second quarter fiscal 2022 financial results on November 4, 2021

REDWOOD CITY, Calif., Nov 02, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results for the second quarter ended September 30, 2021, on Thursday, November 4, 2021, after the close of the market.

Read Moreabout Biotricity To Report Second Quarter Fiscal 2022 Financial Results On November 4 2021

Biotricity launches Biocare Cardiac application for Samsung’s Galaxy Watch4 series

REDWOOD CITY, Calif., Oct 07, 2021 (ACCESSWIRE) — Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac – a personal, cardiac health application for individuals diagnosed with or at risk for cardiovascular disease. Designed to be used with Samsung’s Galaxy Watch4 series, the Biocare Cardiac application continuously collects users’ daily activities and provides critical information on their heart performance, empowering patients to better understand and manage their heart conditions.

Read Moreabout Biotricity Launches Biocare Cardiac Application For Samsungs Galaxy Watch4 Series

Biotricity to discuss expansion of remote monitoring medical device products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd

REDWOOD CITY, Calif., Sep 21, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that its Chief Executive Officer Dr. Waqaas Al-Siddiq is scheduled to present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2021 at 2:55 p.m. ET.

Read Moreabout Biotricity To Discuss Expansion Of Remote Monitoring Medical Device Products At Oppenheimer Fall Healthcare Life Sciences Medtech Summit On September 22nd

Biotricity unveils “Biokit” with 3 personal medical devices to expand into cardiac disease management

REDWOOD CITY, Calif., Sep 14, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it has developed a personal medical device kit, Biokit, a bundled home-use set comprised of a digital thermometer, a pulse oximeter, and a blood pressure cuff. All three devices are FDA cleared, wireless capable and integrate into the Biotricity ecosystem, a platform for interconnectivity. This is the next step in the evolution of the Bioflux solution, where other available tools are fully integrated to create a complete solution for remote cardiac monitoring.

Read Moreabout Biotricity Unveils Biokit With 3 Personal Medical Devices To Expand Into Cardiac Disease Management

Biotricity announces closing of exercise of underwriter’s option to purchase additional common stock

REDWOOD CITY, Calif., Sep 13, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that the underwriter of its previously announced underwritten public offering which closed on August 30, 2021, has partially exercised its option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commission. After giving effect to the sale of an aggregate of 382,331 additional shares pursuant to the exercise of the option, the total number of shares of common stock sold by the Company in the offering increased to 5,382,331 for total gross proceeds of approximately $16 million before deducting underwriting discounts and commissions and other offering expenses. The partial exercise of the option will be the final exercise by the underwriter of the option.

Read Moreabout Biotricity Announces Closing Of Exercise Of Underwriters Option To Purchase Additional Common Stock

Biotricity to discuss sales expansion, recent financing, and wearable medical device portfolio expansion at H.C. Wainwright Conference

REDWOOD CITY, Calif., Sep 08, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today reported its CEO Waqaas Al-Siddiq is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference, which will be available on-demand starting at 7:00 a.m. ET on Monday, September 13, 2021 (details provided below).

Read Moreabout Biotricity To Discuss Sales Expansion Recent Financing And Wearable Medical Device Portfolio Expansion At H C Wainwright Conference

Biotricity completes Nasdaq listing

REDWOOD CITY, Calif., Aug 30, 2021 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the closing of an underwritten public offering of 5,000,000 shares of common stock of the Company for total gross proceeds to the Company of approximately $15 million. The offering was priced at $3.00 per share. In addition, the Company has granted the underwriter of the offering a 30-day option to purchase an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, working capital, potential acquisitions, and other business opportunities. In connection with the offering the Company’s common stock, on August 26, 2021 the Company common stock was listed on the Nasdaq Capital Market under the symbol “BTCY”.

Read Moreabout Biotricity Completes Nasdaq Listing

Biotricity announces proposed underwritten public offering of common stock in connection with expected Nasdaq listing

REDWOOD CITY, Calif., Aug 25, 2021 (ACCESSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the Company expects to grant the underwriter of the offering a 30-day option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commissions. In connection with the offering the Company’s common stock is expected to be listed on the Nasdaq Capital Market under the symbol “BTCY”. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Read Moreabout Biotricity Announces Proposed Underwritten Public Offering Of Common Stock In Connection With Expected Nasdaq Listing

Biotricity reports 290% revenue growth year over year in record first quarter

REDWOOD CITY, Calif., Aug 16, 2021 (ACCESSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal 2022 first quarter, which ended June 30, 2021. Full financial results will be posted on EDGAR later today. Biotricity’s Q1 results maintain a trend of both sequential and year over year (YoY) growth, with revenue once again setting a new quarterly record.

Read Moreabout Biotricity Reports 290 Revenue Growth Year Over Year In Record First Quarter

Biotricity to report first quarter Fiscal 2022 financial results on August 16, 2021

REDWOOD CITY, Calif., Aug 12, 2021 (ACCESSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results for the first quarter of fiscal 2022, ended June 30, 2021, on Monday, August 16, 2021, after the close of the market.

Read Moreabout Biotricity To Report First Quarter Fiscal 2022 Financial Results On August 16 2021

Biotricity’s 2021 fiscal fourth quarter growth trend continues into fiscal 2022

REDWOOD CITY, Calif., Jul 07, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced preliminary revenue results guidance for its 2022 fiscal first quarter, ended June 30, 2021.

Read Moreabout Biotricitys 2021 Fiscal Fourth Quarter Growth Trend Continues Into Fiscal 2022

Biotricity to report fourth quarter fiscal 2021 and financial results on June 15, 2021

REDWOOD CITY, Calif., Jun 09, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY) Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results for the fourth quarter and full fiscal year 2021, ended March 31, 2021, on Tuesday, June 15, 2021, after the close of the market.

Read Moreabout Biotricity To Report Fourth Quarter Fiscal 2021 And Financial Results On June 15 2021

Biotricity to present at 2021 LD Micro Invitational XI

REDWOOD CITY, Calif., Jun 01, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, announced today that its CEO Waqaas Al-Siddiq will be presenting virtually at the upcoming LD Micro Invitational XI event on Tuesday, June 8, 2021, at 11:30 a.m. EDT (8:30 a.m. PDT).

Read Moreabout Biotricity To Present At 2021 Ld Micro Invitational Xi

Biotricity announces 2021 uplisting strategy to major exchange

REDWOOD CITY, Calif., May 25, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is pleased to announce that it has begun executing on its strategy towards an uplist to a National Exchange in 2021. Waqaas Al-Siddiq, CEO of Biotricity previously mentioned this as a top priority for 2021.

Read Moreabout Biotricity Announces 2021 Uplisting Strategy To Major Exchange

Biotricity to present its disruptive medical technologies at the Benzinga Global Small Cap Conference on May 14

REDWOOD CITY, Calif., May 14, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is pleased to announce that its CEO Waqaas Al-Siddiq is scheduled to present at the Benzinga Global Small Cap Conference, being held virtually on May 13-14, 2021.

Read Moreabout Biotricity To Present Its Disruptive Medical Technologies At The Benzinga Global Small Cap Conference On May 14

Biotricity to report record revenue results for fiscal 2021

REDWOOD CITY, Calif., Apr 14, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is pleased to announce another record year in its revenue growth based on its unaudited, preliminary financial results for its fiscal year ended March 31, 2021. Full audited financial results will be filed with the SEC on EDGAR prior to June 14, 2021.

Read Moreabout Biotricity To Report Record Revenue Results For Fiscal 2021

Biotricity, Inc. to present at Maxim Group’s 2021 Inaugural Emerging Growth virtual conference

REDWOOD CITY, Calif., Mar 15, 2021 (ACCESSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is pleased to announce that CEO Waqaas Al-Siddiq will present at Maxim Group’s Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021.

Read Moreabout Biotricity Inc To Present At Maxim Groups 2021 Inaugural Emerging Growth Virtual Conference

Biotricity reports record quarter; earns $1 million in quarterly revenue for the first time

REDWOOD CITY, Calif., Feb 11, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial results for its fiscal 2021 third quarter, which ended December 31, 2020. Full financial results will be posted on EDGAR on February 16, 2021. Biotricity’s Q3 results continued a trend of both sequential and year over year revenue growth, with revenue setting a new quarterly record in the fiscal third quarter.

Read Moreabout Biotricity Reports Record Quarter Earns 1 0 Million In Quarterly Revenue For The First Time

Biotricity to report third quarter fiscal 2021 financial results on February 11, 2021

REDWOOD CITY, Calif., Feb 08, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the highlights of its financial results for the third quarter of fiscal 2021, ended December 31, 2020, on Thursday, February 11, 2021, after the close of the market. Full financial results will be filed and available on Tuesday February 16, 2021.

Read Moreabout Biotricity To Report Third Quarter Fiscal 2021 Financial Results On February 11 2021

Biotricity completes $9.5M of convertible promissory notes to institutional and retail investors

REDWOOD CITY, Calif., Jan 20, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of closings pursuant to which it sold an aggregate gross proceeds of $9,557,500 of convertible promissory notes to institutional and retail investors in separate offerings. The convertible notes convert into the Company’s common stock at a conversion price equal to 75% of the volume weighted average price of the common stock for the five trading days prior to the conversion date. Additionally, the Company will issue the investors in the offering cash warrants based on the amount of promissory notes converted by the investors. The Company believes that conversion of these promissory notes will be instrumental in the Company’s path towards a senior market listing.

Read Moreabout Biotricity Completes 9 5m Of Convertible Promissory Notes To Institutional And Retail Investors

Biotricity submitted 510(k) U.S. FDA filing for Biotres

REDWOOD CITY, Calif., Jan 05, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA), on December 31 2020, for Biotres. The company expects this process to take at least 4 months, and if the Company’s 510(k) application is cleared by the FDA the Company expects a product launch thereafter.

Read Moreabout Biotricity Submitted 510k U S Fda Filing For Biotres

Biotricity to present at the 13th annual LD Micro main event and host virtual one-on-one meetings with investors

REDWOOD CITY, Calif., Dec 09, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that CEO Waqaas Al-Siddiq and CFO John Ayanoglou are scheduled to present to a live audience at the 13th Annual LD Micro Main Event virtual investor conference on December 15th, 2020 at 10:20 am Pacific Time (1:20 pm ET). The online presentation will be webcast live and available for replay at the investor relations section of Biotricity’s website.

Read Moreabout Biotricity To Present At The 13th Annual Ld Micro Main Event And Host Virtual One On One Meetings With Investors

Biotricity reports results for the quarter ended September 30, 2020

REDWOOD CITY, Calif., Nov 17, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, reported results for the three months ended September 30, 2020. During the three months ended September 30, 2020, the Company earned device sales and technology fees totaling $744,585. Expansive growth into new clinics adopting Bioflux resulted in September being the Company’s highest revenue-producing month to date. Full results are available on EDGAR or in the Financial Section of the Company’s website.

Read Moreabout Biotricity Reports Results For The Quarter Ended September 30 2020

Biotricity launches Biocare Telemed for safe and convenient remote patient care

REDWOOD CITY, Calif., Nov 12, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today introduced Biocare Telemed, a virtual clinic that provides user-friendly access for patients to receive outstanding medical care and remote patient cardiac monitoring from their physician of choice in the safety and comfort of their home.

Read Moreabout Biotricity Launches Biocare Telemed For Safe And Convenient Remote Patient Care

Biotricity accelerates shift to remote monitoring with Bioflux® Direct program

REDWOOD CITY, Calif., Sep 29, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® Direct Program. The new offering ships Bioflux devices directly to at-risk patients who need to self-isolate or avoid in-person clinic visits.

Read Moreabout Biotricity Accelerates Shift To Remote Monitoring With Bioflux Direct Program

Biotricity provides quarter update and announces continued growth

REDWOOD CITY, Calif., Sep 01, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its technology service revenues, demonstrating a continued pattern of improved growth for its first fiscal quarter ending June 30, 2020. During these three months, Biotricity, had combined device sales and technology fee revenues that were 38.2% higher than those of the corresponding period in the preceding year and 24.5% higher than the preceding quarter, ended March 31, 2020, marking its most successful quarter to date.

Read Moreabout Biotricity Provides Quarter Update And Announces Continued Growth

Biotricity signs agreement with Telemedicine Company

REDWOOD CITY, Calif., Aug 12, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has entered into an Agreement that establishes terms under which Biotricty will enter into a licensing agreement. Biotricity has negotiated to license, with the exclusive right to acquire MD Matrix and its telemedicine platform that includes real-time streaming of medical devices, making it a perfect fit for the Bioflux platform. The addition of telemedicine provides additional growth for the Company.

Read Moreabout Biotricity Signs Agreement With Telemedicine Company

Biotricity receives FDA clearance for Bioflux® Software II System

REDWOOD CITY, Calif., Aug 04, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) clearance from the FDA for its Bioflux Software II System.

Read Moreabout Biotricity Receives Fda Clearance For Bioflux Software Ii System

Biotricity partners with Verizon to develop EMS solutions

REDWOOD CITY, Calif., Jul 14, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon (NYSE: VZ) to develop EMS solutions for First Responders by integrating its Bioflux solution. Bioflux is a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of patients’ ECG information. Integrating the Bioflux solution into Verizon’s EMS platform realizes an unmet need for First Responders, enabling them to access critical, potentially life-saving data in real-time and respond immediately in a crisis.

Read Moreabout Biotricity Partners With Verizon To Develop Ems Solutions

Biotricity shows continued growth through its preliminary year-end guidance and provides calendar second quarter update

REDWOOD CITY, Calif., Jul 08, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today provided guidance on its financial results for the year ended March 31, 2020, announcing that it has experienced increases of approximately 260% in gross annual revenues, year over year, and 113% quarter over quarter. This guidance is being provided in advance of filing audited results within its 10-K, which it anticipates filing prior to July 15, 2020.

Read Moreabout Biotricity Shows Continued Growth Preliminary Year End Guidance Provides Calendar Second Quarter Update

Biotricity FDA submission update

REDWOOD CITY, Calif., May 20, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to announce that it recently received communication from the FDA stating that its 510(k) submission for its next generation Bioflux Software Device is now in the Substantiative Phase of the review process with an expected response by the end of June. The Company is confident in its FDA submission process, having received two previous 510(k)s for its Bioflux Device and Bioflux Software.

Read Moreabout Biotricity Fda Submission Update 2

Biotricity expands Board of Directors with new appointment

REDWOOD CITY, Calif., Apr. 30, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced that Steve Salmon has joined its Board of Directors. Mr. Salmon will bring additional expertise in business development transactions, market development, finance, technology, and capital market. His most recent experience was as a Venture Capitalist for Latterell Venture Partners, where he managed a number of portfolio companies.

Read Moreabout Biotricity Expands Board Of Directors With New Appointment

One America News (OAN) interviews Biotricity’s CEO for his insight into telemedicine and how remote diagnostics can take it further

REDWOOD CITY, Calif., April 23, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was recently interviewed on OAN to discuss Telemedicine and how Biotricity and its Bioflux solution can be used to expand the use cases for telemedicine.

Read Moreabout One America News Oan Interviews Biotricitys Ceo For His Insight Into Telemedicine And How Remote Diagnostics Can Take It Further

Biotricity’s CEO interviewed on Newsmax to discuss remote patient monitoring and telemedicine

REDWOOD CITY, Calif., Apr. 21, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was recently interviewed on Newsmax to discuss Remote Patient Monitoring, Telemedicine and how Biotricity and its Bioflux solution is currently being used to remotely monitor patients.

Read Moreabout Biotricitys Ceo Interviewed On Newsmax To Discuss Remote Patient Monitoring And Telemedicine

Biotricity’s real-time monitoring Bioflux device can help identify life threatening QT prolongation in COVID-19 patients

REDWOOD CITY, Calif., Apr. 07, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Bioflux® units are designed for QT interval analysis, a section of the ECG, to identify serious risks like QT prolongation. QT prolongation is a measure of delayed ventricular repolarization, which can cause sudden cardiac death. QT is becoming an important factor for COVID-19 patients, as some of the drugs being used can cause QT prolongation as a side effect, leading to sudden cardiac death. Bioflux can be used to remotely monitor this.

Read Moreabout Biotricitys Real Time Monitoring Bioflux Device Can Help Identify Life Threatening Qt Prolongation In Covid 19 Patients

Biotricity issues COVID-19 update

REDWOOD CITY, Calif., Mar. 20, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, issued a response today to the ongoing COVID-19 impact, reassuring its valued customers, shareholders, and partners that business will continue as usual. The company has taken steps to ensure that its customers have continued access to an increased supply of Bioflux® units as demand for remote patient monitoring grows during this time.

Read Moreabout Biotricity Issues Covid 19 Update

Biotricity launches innovative pain management product with NeuPath Health

REDWOOD CITY, Calif., Mar. 10, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has launched its innovative pain management product with CPM Centres for Pain Management, a subsidiary of NeuPath Health, Canada’s largest provider of chronic pain management services. This is Biotricity’s first expansion into the larger chronic care/pain management market, where it hopes to address gaps in technology solutions for patient diagnosis and management.

Read Moreabout Biotricity Launches Innovative Pain Management Product Neupath Health

Biotricity posts calendar Q4 results that show continued growth

REDWOOD CITY, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced calendar fourth quarter financial results for the three months which ended December 31, 2019.

Read Moreabout Biotricity Posts Calendar Q4 Results Show Continued Growth

Biotricity files a 510(k) application for its advanced ECG analysis software

REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) application for US FDA clearance for its next generation, advanced ECG analysis software. The Company anticipates receiving a clearance by end of May 2020.

Read Moreabout Biotricity Files 510k Application Advanced Ecg Analysis Software

Biotricity prepares its filing for a 510(k) application for its advanced ECG analysis software

REDWOOD CITY, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it is finalizing its FDA filing for its next generation, advanced ECG analysis software with an expectation to file a 510(k) clearance application with the US FDA by end of February 2020.

Read Moreabout Biotricity Prepares Filing 510k Application Advanced Ecg Analysis Software

x

How Wearable ECG Technology Is Transforming Heart Care

Read Moreabout X 2

x

How Wearable ECG Technology Is Transforming Heart Care

Read Moreabout X

Biotricity completes $6M investment from private investor

REDWOOD CITY, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a $6M investment from its long term Private Investor in the form of a Preferred Equity transaction. Under the terms of the deal, the Preferred Equity will have a 12% per annum return, with an option to convert into Common Stock after 2 years at a 15% discount to the stock price at the time of conversion.

Read Moreabout Biotricity Completes 6m Investment Private Investor

Biotricity completes development of its ECG patch platform

REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed development of its ECG patch platform. An extension of the company’s award-winning Bioflux® device, Biopatch is ideal for patients with less complicated cardiac conditions. The patch leverages the advanced diagnostic capabilities of Bioflux® in a miniaturized form factor with 3 standard electrodes but no lead wires.

Read Moreabout Biotricity Completes Development Ecg Patch Platform

Biotricity shows continued growth in core revenue for fiscal Q2

REDWOOD CITY, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced financial results for its fiscal second quarter ending on September 30, 2019. The company’s financial results reflect a strong growth trajectory and positive commercialization progress.

Read Moreabout Biotricity Shows Continued Growth Core Revenue Fiscal Q2

Biotricity CEO Waqaas Al-Siddiq in live interview on FOX business network

REDWOOD CITY, Calif., Sep. 10, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), today announced that its CEO and Founder Waqaas Al-Siddiq will be on The Claman Countdown airing on Fox Business Network (FBN) on Wednesday, September 11th at 3:15 PM EDT. Mr. Al-Siddiq will discuss the current economic climate and how the Chinese tariff affects small and growing medical device companies, and ultimately, US patients. He will also discuss Biotricity’s focus on innovation in the remote patient monitoring space, and the company’s aim to create better access to accurate, high quality healthcare.

Read Moreabout Biotricity Ceo Waqaas Al Siddiq Live Interview Fox Business Network

We’re hiring an intern!

Biotricity Inc., an innovative medical technology company, has an immediate opening for a Health Outcome Improvements Intern. We are looking for the young and hungry! This is an exciting opportunity to work for a start-up company and delve deep into the biotechnology sector, attaining transferable skills and experience that you will need to work in a variety of healthcare, technology, and business administration specialties.

Read Moreabout Were Hiring An Intern

Biotricity reports fiscal Q1 results showing a strong growth trajectory

REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced financial results for its first quarter ending June 30, 2019. The company’s financial results reflect a strong growth trajectory and positive commercialization progress.

Read Moreabout Biotricity Reports Fiscal Q1 Results Showing Strong Growth Trajectory

Biotricity CEO Waqaas Al-Siddiq in live interview on Yahoo Finance

REDWOOD CITY, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), today announced that its CEO and Founder Waqaas Al-Siddiq will be on Yahoo Finance’s On the Move show on Tuesday, August 20th, airing at 11:45 AM EDT. As of July 2019, with approximately 70 million unique monthly visitors, Yahoo Finance was ranked the most popular investment and finance website in the United States, by number of visits.

Read Moreabout Biotricity Ceo Waqaas Al Siddiq Live Interview Yahoo Finance

Biotricity audited year-end results demonstrate execution of commercial growth plans

REDWOOD CITY, Calif., Jul 29, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed its 10-K filing for the fiscal year, which ended March 31, 2019. Audited results for this period indicate a 51.4 percent quarter over quarter increase in revenues, comprised of device sales and recurring technology fee revenues. The increase in revenues reaffirms the Company’s positive commercialization progress.

Read Moreabout Biotricity Audited Year End Results Demonstrate Execution Commercial Growth Plans

Biotricity doubles sales force – expands device fleet by 59%

REDWOOD CITY, Calif., Jun 19, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has expanded its fleet of Bioflux devices to meet customer demand. Bioflux is a real-time, single-unit mobile cardiac telemetry (MCT) solution, that is used by physicians to remotely monitor a patient’s ECG information.

Read Moreabout Biotricity Doubles Sales Force Expands Device Fleet 59

Biotricity provides fiscal fourth quarter update: Sales force expansion to fuel growth

REDWOOD CITY, Calif., May 07, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today provided a progress report for its fiscal 2018 fourth quarter, which ended March 31, 2019. The company continues to execute its plans to grow its sales force, expand its geographic footprint, and reach more Americans with its life-saving technology.

Read Moreabout Biotricity Provides Fiscal Fourth Quarter Update Sales Force Expansion Fuel Growth

Biotricity announces expanded R&D team for the development of its fetal/maternal and ambulatory wellness monitoring systems

REDWOOD CITY, Calif., Mar. 19, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to announce further buildout of its R&D team, with the engagement of the Biomedical Engineering Department at the University of Calgary.

Read Moreabout Biotricity Announces Expanded Rd Team Development Fetalmaternal Ambulatory Wellness Monitoring Systems

Biotricity achieves significant milestones for both fetal/maternal and ambulatory wellness monitoring systems

REDWOOD CITY, Calif., Mar. 06, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that is has achieved significant progress in their University of Calgary-based R & D program for their latest wellness monitoring systems. Clinical data collection has commenced for both its fetal/maternal and ambulatory adult heart rate variability (HRV) monitoring systems.

Read Moreabout Biotricity Achieves Significant Milestones Fetalmaternal Ambulatory Wellness Monitoring Systems

Biotricity issues statement regarding recent promotional activity

REDWOOD CITY, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), (the “Company”) announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent promotional activity concerning its common stock.

Read Moreabout Biotricity Issues Statement Regarding Recent Promotional Activity

Biotricity completes alpha version of Deep Data diagnostic solution

REDWOOD CITY, Calif., Jul. 24, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has completed the alpha version of Bioflux 2.0’s deep data diagnostic solution in accordance with FDA arrhythmia diagnostic standards.

Read Moreabout Biotricity Completes Alpha Version Deep Data Diagnostic Solution

Biotricity’s Bioflux named best remote patient monitoring solution by MedTech breakthrough

REDWOOD CITY, Calif., Jun. 06, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the prestigious MedTech Breakthrough Award 2018 for Best Remote Patient Monitoring Solution.

Read Moreabout Biotricitys Bioflux Named Best Remote Patient Monitoring Solution Medtech Breakthrough

Cellular connectivity & healthcare: A new echelon of innovation

Cellular connectivity is fast becoming integral to healthcare; according to Market Watch, global investment in Internet of Things (IoT) from the medical industry should reach $410 billion by 2022, and much of this investment will come directly from cellular IoT markets. Cellular connectivity could improve operational efficiency, enhance security, and push healthcare towards a more preventive model by better supporting IoT connected medical devices.

Read Moreabout Cellular Connectivity Healthcare New Echelon Innovation

San Antonio Endovascular & Heart Institute first to deploy Biotricity’s new Bioflux remote monitoring device

REDWOOD CITY, Calif., Apr. 23, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that the San Antonio Endovascular & Heart Institute (SAEHi) – a practice specializing in diagnosing, treating, managing, and researching diseases and disorders of the heart and vascular system – deployed Biotricity’s Bioflux on April 6, 2018. SAEHi will leverage the real-time, high-precision mobile cardiac telemetry solution to assist in the diagnosis of cardiac arrhythmias, enhance patient outcomes, improve patient compliance, and curb healthcare costs.

Read Moreabout San Antonio Endovascular Heart Institute First Deploy Biotricitys New Bioflux Remote Monitoring Device

Listen to this: MedTech and the power of the human voice

Augmenting rules-based systems with voice recognition and analysis offers multiple benefits for healthcare. For the chronic disease population, which comprises mostly older adults, using voice as a user interface could enhance medical device usability by helping patients overcome problems of failing eyesight, limited hand dexterity, arthritis, and a lower rate of technology adoption. Emerging research has also explored the possibility of using voice samples to diagnose disease.

Read Moreabout Listen Medtech Power Human Voice

Biotricity appoints Casey Shattuck as new VP of Sales to spearhead Bioflux launch

REDWOOD CITY, Calif., Mar. 12, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the company has appointed Mr. Casey Shattuck to serve as the Company’s Vice President of Sales. With extensive experience in leading cardiac and vascular “start-up” companies which have led to numerous successful acquisitions, Mr. Shattuck’s immediate priority will be to oversee the commercialization of Bioflux, a real-time, high-precision mobile cardiac telemetry solution for customers.

Read Moreabout Biotricity Appoints Casey Shattuck New Vp Sales Spearhead Bioflux Launch

Abnormal heart rhythm: All about arrhythmias

Here at Biotricity we are trying to raise awareness about heart rhythm abnormalities, also known as arrhythmias such as atrial fibrillation. The human heart is a magnificent piece of natural engineering made up of an intricate plumbing system and a complex electrical system that work together to ensure your heart maintains a steady beat. Each day the average human heart beats 100,000 times, these beats are controlled by electrical impulses which pump around 7000 liters of blood through the arteries and veins of the body’s plumbing system. A problem with the heart’s electrical system can cause the heart to beat abnormally, giving rise to a heart rhythm abnormality.

Read Moreabout Abnormal Heart Rhythm Arrhythmias

Biotricity update for shareholders

REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has witnessed a phenomenal fourth quarter

Read Moreabout Biotricity Update Shareholders

Medical wearables: Next generation devices will change healthcare

Medical wearable devices could transform the healthcare industry with continuous and real-time monitoring, providing quicker diagnosis and treatment of conditions. To date, lifestyle and fitness wearables have proliferated and few steps have been taken to incorporate medical wearables into the healthcare system. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how successfully implementing medical wearables in a healthcare system depends on overcoming two key problems: providing medically relevant data and incorporating wearables into current billing practices.

Read Moreabout Medical Wearables Next Generation Devices Will Change Healthcare

Heart attack: What it is and why does it happen?

Every 40 seconds, someone in the United States has a heart attack. Over the course of a year, approximately 790,000 Americans have a heart attack, and of these cases 580,000 are a first heart attack and 210,000 are subsequent events. Coronary artery disease (CAD) is the main cause of heart attack, and the most common type of heart disease. The disease manifests when the arteries that supply blood to the heart muscle become hardened and narrowed, which can subsequently cause heart attacks, chest pains, or strokes.

Read Moreabout Heart Attack What Why

Biotricity expands its R&D effort to capitalize on artificial intelligence

REDWOOD CITY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is currently expanding its research and development to include artificial intelligence (AI) to optimize its proprietary remote patient monitoring platform for future use. When studying the unique characteristics of a patient using a remote monitoring device for a chronic condition such as cardiovascular disease, AI could be used to track a patient’s progress, determine if they’re adherent with a practitioner’s guidelines, recommend action to increase adherence, offer a means of patient engagement, and provide predictive action to avert negative health outcomes. Properly executed this could lead to an improvement in detection quality and patient outcomes while driving down costs and potentially providing another product opportunity for Biotricity.

Read Moreabout Biotricity Expands Rd Artificial Intelligence

Biotricity closes a registered direct financing and paves the way for Bioflux launch

REDWOOD CITY, CA – Dec. 22, 2017 (GLOBE NEWSWIRE) – Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the entry into agreements and closing relating to the sale of 450,164 shares of its common stock at an offering price of $5.50 per share. The gross proceeds from the offering will be approximately $2.5M before deducting estimated offering expenses. The shares of common stock have been sold to existing investors of the Company.

Read Moreabout Biotricity Closes Registered Direct Financing Paves Way Bioflux Launch

Biotricity expands team with new CFO as it prepares for commercialization

REDWOOD CITY, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) — Biotricity Inc. (BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced it has appointed John Ayanoglou as its new Chief Financial Officer (CFO), effective immediately. Mr. Ayanoglou will help establish formal financial processes and accelerate Biotricity’s go-to-market strategy. He will report to Biotricity Founder and CEO Waqaas Al-Siddiq and serve as a member of the company’s Leadership Team.

Read Moreabout Biotricity Expands Team New Cfo Prepares Commercialization

Using technology innovations to get ahead in a value-based world

In a healthcare landscape riddled with rising costs and an increase in chronic disease, automation could be incorporated into a physician’s workflow to bring value-based care that is both cost-effective and patient centric. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how the shift towards automation in healthcare could streamline healthcare workflow, improve long-term care management, and improve adherence and knowledge through digital engagement.

Read Moreabout Using Tech Innovations Value Based World

Biotricity announces support of progressive changes in telemedicine healthcare policy

REDWOOD CITY, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, acknowledges the importance of telemedicine by announcing its support of the proposed changes in healthcare policy and its expansion into healthcare practices. Biotricity believes that the rise of telemedicine at the federal and state levels points to a healthcare shift that promotes remote care delivery. This direction could create opportunities for remote patient monitoring solutions that can be integrated within telemedicine.

Read Moreabout Biotricity Supports Telemedicine Policy

Update on Biotricity 510(k) filing

REDWOOD CITY, Calif., July 05, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has received feedback on its hardware 510(k) filing requesting additional information. Biotricity is compiling the information and expects to provide this within the next three weeks. Once this is submitted, the company expects to receive feedback by end of August.

Read Moreabout Update Biotricity 510k Filing

Biotricity receives ethics approval to investigate mobile wireless fetal monitoring

REDWOOD CITY, Calif., June 20, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced it has received ethics approval to conduct a study that will investigate and validate a mobile wireless fetal heart rate variability (HRV) monitor. Achieving ethics approval to conduct a clinical investigation is a significant accomplishment as the responsible institution must review the entire project from design, methodology, risk, goals, and other factors before proceeding.

Read Moreabout 3409 2

Biotricity provides mid-year update for shareholders

REDWOOD CITY, Calif., June 06, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has had a strong start to 2017 with a number of key developments.

Read Moreabout 3399 2

How modern technology approaches are set to change the healthcare paradigm

The movement towards personalized medical devices in healthcare has given rise to the “patient-consumer.” Healthcare providers are now incorporating wireless devices into healthcare settings and using them to engage patients. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how medical technology should be interoperable, iterative, and capable of providing actionable feedback to facilitate patient-consumer adoption.

Read Moreabout Modern Technology Change Healthcare Paradigm

Biotricity brings together industry experts to advise on post-diagnostic cardiac care

REDWOOD CITY, Calif., May 09, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has formulated a panel of industry experts to help advise and develop guidelines for post-diagnostic cardiac care. The panel is comprised of Global to Local’s research and innovation arm, faculty members from the Cumming School of Medicine at the University of Calgary, and members of Biotricity’s medical advisory board.

Read Moreabout Biotricity Brings Industry Experts Advise Post Diagnostic Cardiac Care

Biotricity changes year-end to move closer to qualifying to list on a National Exchange

REDWOOD CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has changed its year-end as it prepares to get ready to pursue a listing on a national securities exchange such as NYSE:MKT or Nasdaq. As certain national securities exchanges would require at least one full year of audited financials of the Company, this step will fulfill that requirement. There are several additional steps that are required before Biotricity can formally begin the process.

Read Moreabout Biotricity Changes Year End Move Closer National Exchange

Biotricity files for its second and final FDA 510(k) to bring Bioflux solution to market

REDWOOD CITY, Calif., April 12, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a second and final 510(k) for the hardware portion of its Bioflux solution with the U.S. Food and Drug Administration (FDA).

Read Moreabout Biotricity Files Final Fda 510k Bioflux Solution

World leading 3D gait analysis and biomechanics expert Dr. Reed Ferber joins Biotricity board of advisors

REDWOOD CITY, Calif., March 27, 2017 — Biotricity Inc. (OTCQB:BTCY), a healthcare technology company committed to delivering innovative, medically-relevant biometric remote monitoring solutions, today announced that Dr. Reed Ferber Ph.D., ATC, will join its Board of Advisors (BOA). As a recognized visionary in gait biomechanics and bioengineering, Dr. Ferber specializes in the research and clinical treatment of lower extremity injuries and is internationally recognized as an expert in running injuries, clinical biomechanics, and rehabilitation research.

Read Moreabout Gait Analysis Biomechanics Expert Dr Reed Ferber Joins Biotricity

Maintenance intervention could be the key to maintaining weight loss

Maintenance intervention could be the key to successfully sustaining weight loss, suggests a new study. After initial weight loss, most people regain weight at an average rate of 2 to 4 pounds per year.

Read Moreabout Maintenance Intervention Weight Loss

Biotricity selects Providence Enterprise to manufacture company’s remote biometric monitoring solutions

REDWOOD CITY, Calif., March 14, 2017 — Biotricity Inc. (OTCQB:BTCY), a healthcare technology company committed to delivering innovative, medically-relevant biometric remote monitoring solutions, today announced that it has selected contract manufacturer Providence Enterprise to mass produce its medical grade and IoT-connected healthcare devices.

Read Moreabout Biotricity Selects Providence Enterprise Manufacture Biometric Solutions

Heart disease: A news roundup on how women experience heart disease differently

Women are more likely to die from heart disease than men. [1] This month is Heart Health Awareness month and already there have been a myriad articles published on the subject. This article presents a roundup of the exciting medical discoveries from the past month.

Read Moreabout Heart Disease Women News

Leveraging technology for socially disadvantaged communities

The growing health divide in the U.S. is contemporaneous with the digital divide. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how smartphone technologies such as text messaging, health apps, and wireless monitoring sensors designed to function within a social context could help bridge these divides and improve health outcomes across communities. These technologies could provide support to disadvantaged communities, enhance care delivery, and provide both patients and physicians with timely, useful health data.

Read Moreabout Leveraging Technology Socially Disadvantaged Communities

Artificial intelligence plays a smart role in better healthcare delivery

The consumerization of artificial intelligence (AI) in healthcare represents the mainstream physician and patient adoption of technologies with AI capabilities for diagnostic and care management purposes. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how remote patient monitoring (RPM) technologies with AI capabilities could result in improved health outcomes for patients with chronic disease while revolutionizing care management costs.

Read Moreabout Artificial Intelligence Smart Role Better Healthcare

Heart disease and stroke are linked to stress

Researchers have recently found a link between the amygdala and heart disease, otherwise known as cardiovascular disease (CVD). The amygdalae, or the “fear center” in the brain, are a set of small lobes in the rear of the brain that are linked to various forms of stress. Subjects of the study with over-active sets of amygdala were more likely to have a heart attack, stroke, or other serious heart event within the next 4 to 5 years.

Read Moreabout Heart Disease Stroke Linked Stress

How virtual reality is shaping the healthcare industry

Virtual reality is not just for entertainment. It can be applied in numerous vertical industries and has been explored in the healthcare sector for decades. As VR becomes more affordable and accessible to the mass market its impact on health care is palpable. According to Josh Sackman, president of Applied VR, “Health care is ultimately where we’ll see VR’s biggest impact to date on humanity.”

Read Moreabout Virtual Reality Healthcare Industry

Data revolution will initiate technology’s aim to improve healthcare

That the average healthcare experience will happen with just a few taps of a smart-device is no longer science fiction. Eradicating wait-times, endless paperwork, and the trek to a doctor for simple injuries, common diagnosis, or chronic-care check-ins are just some of the processes that online medical practices like Sherpaa and the search engine Melody aim to eliminate.

Read Moreabout Data Revolution Improve Healthcare

Biotricity to showcase clinical-grade remote ECG monitoring solution Bioflux at Mobile World Congress 2017

REDWOOD CITY, CA, January 24, 2017 – Biotricity Inc. (OTC.QB: BTCY), a healthcare technology company committed to delivering innovative, medically-relevant biometric remote monitoring solutions, will demonstrate its IoT-connected medical device Bioflux, powered by AT&T, at Mobile World Congress (MWC) 2017. One of the biggest annual showcases for connected technology, MWC will be held February 27 — March 3 in Barcelona. Biotricity will showcase how IoT- Connected Healthcare devices can assist in the diagnosis of heart conditions in AT&T’s booth (#4A10).

Read Moreabout Biotricity Bioflux Mwc 2017

Social interaction can improve chronic-care management

“Health care is serious business, but who says it can’t be social?” says Dr. Asch, author of a new study that suggests social incentives may be a more effective way to improve patients’ health. Results from Dr. Asch’s investigation showed that chronic-care patients working with peers, friends, and family had a markedly increased decline in glycated hemoglobin levels as opposed to those who worked with clinical staff. The study recommend that hospitals engineer social incentives among patients’ peers and family members in order to improve health outcomes.

Read Moreabout Social Improve Chronic Care

Clinical relevance spells success for medical wearables

In a recent interview, Biotricity’s CEO discusses the importance of ensuring the clinical relevance of medical wearables. The key lies in the distinction between fitness bands, which are not FDA cleared because they are not meant for clinical use, and medical wearables which are benchmarked and can be clinically trusted. He also stresses the importance of fitting new technologies into existing healthcare workflows.

Read Moreabout Clinical Relevance Medical Wearables

The raw food alternative to treating type 2 diabetes

There are myriad causes for Diabetes, but often prediabetes and Type 2 diabetes cases are preventable and, potentially, treatable to the point of being curable. Nutrition is one such treatment, and it is a drum that doctor’s beat often. Taking on the Raw Food Challenge Documentary unveils that the level of lifestyle change isn’t just a change for the participant, but a lifestyle change for their entire family or in-home eating community. Ultimately, the documentary’s message was one that called for people to take preventative care into their own hands, and to do that they need to find or create social support.

Read Moreabout Raw Food Type 2 Diabetes

BMI fallacy proves that diabetes isn’t just a disease of excess

The video entitled, “The New Face of Diabetes” presents the growing diabetes pandemic in India. Of the 1.3 billion people living in India, over 66 million have Type 2 diabetes and the number is estimated to reach 100 million before 2030.1 Add to that the 77 million who have prediabetes and the video has made it’s point—but it goes on to explain the paradox at the heart of this pandemic, the BMI fallacy, and how “excess” may not be the only cause.

Read Moreabout Bmi

Addiction is a chronic disease, not a moral failing

There are 27 million Americans that suffer from addiction to drugs, alcohol, and tobacco. Only 1 in 10 receives help, and the cost of addiction in America is upwards of $440 billion. The problem, according to Surgeon General Vivek Murthy, is not the addicts themselves but the other 27 million Americans harboring a negative, entrenched stigma about drug addicts. The truth is that drug addiction is not a moral failing or a disease of choice but, as the Surgeon General reports, a chronic illness that needs to be treated as such by the public, by the media, and by physicians.

Read Moreabout Addiction Chronic Not Moral

Wearable ECGs could reduce sudden cardiac arrest

When a young person dies during a sporting event, we can’t believe it. When we hear of marathon runners dropping dead from heart attacks, we’re stunned. Being physically fit doesn’t necessarily mean we’re protected against sudden health calamities. People who die from sudden cardiac arrest either ignore the warning signs or never identify them to begin with. SCA still causes about 70 athlete deaths in the U.S. each year, and over 300,000 total deaths.

Read Moreabout Wearable Reduce Sudden Cardiac Arrest

Prediabetic? A review of the CDC’s prediabetes questionnaire

The Centers for Disease Control’s (CDC) website, doihaveprediabetes.org, is an online risk test that is part of the CDC’s 2016 campaign against diabetes. [1] It presents facts like: “1 in 3 American adults is prediabetic” and asks the patient a series of questions before suggesting a course of action. [1] Paula Span’s New York Times article focuses on the delicacies of notifying 80% of American’s over the age of 60 that they are likely to have prediabetes and need to visit their doctor. In the end the advice remains: eat healthy and exercise.

Read Moreabout Prediabetic Review Cdcs Prediabetes Questionnaire

Recent research finds: Obesity has no "universal cure"

A recent New York Times article discusses the research of Dr. Frank Sacks who has found that there is no single diet or cure for obesity. Obesity, like cancer, is not a single disease and as such there is no simple diagnosis or treatment. The Times article chronicles six stories who, with the help of obesity doctors, have found their individual cure.

Read Moreabout Recent Research Finds Obesity No Universal Cure

Life expectancy decreased in the United States, 2015

86,212 more people died in the Unites States in 2015 than in 2014, an increase of 0.1/year. This means that life expectancy for Americans aged 25 to 85 is getting shorter by about 6 months. While these numbers might seem small they are not insignificant because they follow a troubling trend for American life expectancy which, over the past three years, remained static while other developed countries life expectancy rates increased.

Read Moreabout Life Expectancy Decreased United States 2015

Burned-out: The stressed and underperforming employee

Disengaged, burned-out workers cost the United States and Canada upwards of $550 billion a year. Brad Stulberg’s article discusses how the advent of mobile devices has made it difficult for people to disconnect from work and how this has perpetuated a “costly epidemic of burnout. The irony is that people are forcing themselves into a state of burnout in order to keep productivity flowing but, as Stulberg reveals, this is actually counter-productive.

Read Moreabout Burned Out Stress Employee

GenExers and millenials at greater risk of stroke

The latest cardiology research holds bad news for millennials and, if preventative measures aren’t taken, for generations to come. The good news: research unveils that baby boomers born between 1945 and 1954 are the “stroke-healthiest generation.” The bad news: rate of stroke more than doubled in Generation Xers born between 1965 and 1974. If change isn’t made, the trend will likely continue.

Read Moreabout Genexers Millenials Greater Risk Stroke

Remote patient monitoring helps reduce hospital readmissions

The Centers for Medicare and Medicaid Services estimated hospital readmissions were costing Medicare $26 billion annually, $17 billion of which could be avoidable with improvements in post-discharge care of those who suffer from chronic disease. Undeniably, in addition to decreasing the quality of life, chronic diseases drive annual healthcare costs into the billions of dollars. Use of remote monitoring is associated with lower risks of hospitalization, shorter hospital stays, and lower rates of heart failure and stroke hospitalization.

Read Moreabout Remote Patient Monitoring Reduce Readmissions

Partnership Expands Digital Health Coaching, Patient Engagement

More than three-quarters (76 percent) of adults surveyed reported they would use a health tracking device that was clinically accurate and user friendly. The survey, which was conducted in conjunction with Biotricity, points out that patients want to become engaged in their own health; “Patients view themselves as key contributors of health data to manage their own health,” explains Daniel Z. Sands, MD, MPH, co-founder and co-chair of the Society for Participatory Medicine.

Read Moreabout Partnership Expands Digital Health Coaching Patient Engagement

The Proven Health Trackers Saving Thousands of Lives

The article discusses patient monitoring wearables as having great potential in the market because they give patients a warning that things are going wrong before it’s too late, effectively saving many lives. Wearables used in healthcare have the potential to curb risky behavior because, as Mr. Gundotra says, “People start modifying their behavior once they begin monitoring their own health.” In addition, remote monitoring wearables are an incredibly cost-effective health tool.

Read Moreabout Proven Health Trackers Saving Thousands Lives

Biotricity and Global to Local to Develop Chronic Care Solutions to Address Current Gaps in the Market

Biotricity and Global to Local (G2L), a not-for-profit with the goal addressing health and economic disparities in low-income populations, are partnering to use innovative, holistic, and community-driven solutions to address healthcare gaps. The collaboration between Biotricity and G2L will initially focus on building innovative solutions for outcome measurements for individuals suffering from chronic disease. Together these companies hope to empower the individual to take better care of their health.

Read Moreabout Biotricity G2l Develop Chronic Care Sol

New Cases of Diabetes Have Risen by a Third in Just 10 Years: Theresa May says ‘More Needs to be Done’

Theresa May, Prime Minister of England, addresses the growing epidemic of diabetes. Currently, more than 4.5 million adults in the UK now have diabetes, an increase of around 1.5 million since 2005. May, who suffers from type 1 diabetes, said this morning that there is a “huge amount” to be done to raise awareness of the condition, she added that prevention methods could save England’s National Health Service money from costly and life-threatening complications.

Read Moreabout New Cases Diabetes Risen Third Just 10 Years Theresa May Says Needs Done

The true cost of chronic disease and why we need to act now

Almost half of adult Americans current suffer from a chronic illness and the diagnoses are continuing to stack up. The cost of chronic disease on the healthcare system, patients, and physicians weighs heavily on the future health of the US healthcare system and its people. This article discusses the various costs and how proactivity in instituting preventative care is essential for there to be any recourse in the foreseeable future…

Read Moreabout True Cost Chronic Disease Need Act Now

Wearable Technology Devices to Focus More on Health

While fitness trackers and wearable cameras were once the most popular wearable devices, there is now an emerging social emphasis on health and a bigger demand for home care which is expected to drive demand for medical wearables. Biotricity, who’s Biolux has recently received its FDA clearance, is a medical technology company committed to improving healthcare by developing medical grade wearable solutions that aid chronic disease prevention and management.

Read Moreabout Wearable Technology Devices Focus Health

Replace Annual Physicals with Real-Time Biomarker Monitoring

Despite 92% of physicians decrying the usefulness of a yearly physical, Americans believe that these exams are important. While America’s demand for up-to-date, personalized health information is on the rise, doctors seem convinced that this obsession is a waste of time or even socially harmful. Still, everyone agrees that preventive medicine is preferable to reactive medicine. Perhaps, the answer is to work toward developing technologies that allow real-time monitoring of biomarkers.

Read Moreabout Replace Annual Physicals Real Time Biomarker Monitoring

The Shift of Medical Devices to a Home Setting

A recent research report by Meticulous Research estimates that the global home medical devices market is expected to reach $48.47 billion by 2022 with a CAGR of 7.8% over the period of 2016 to 2022. A recent trend of sophisticated wearables with remote monitoring capabilities has emerged. Biotricity Inc. is one of the start-up companies entering the market, they are focusing on biometric monitoring solutions for medical, healthcare and consumer use.

Read Moreabout Shift Medical Devices Home Setting

Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors

Dr. Rony Shimony, MD, FACC and Associate Professor of Medicine and Cardiology at the Icahn School of Medicine at Mount Sinai in New York, joins Biotricity on it’s Board of Advisors (BOA). As an internationally recognized clinical cardiologist who brings to the company over 25 years of experience and vast knowledge and expertise in Cardiovascular Disease, Dr. Shimony will help advise Biotricity as it rolls out its upcoming innovative biometric device.

Read Moreabout Renowned Cardiologist Dr Rony Shimony Joins Biotricity Board Advisors

Biotricity Aims to Revolutionize the Healthcare Sector with Innovative Monitoring Solutions

Biotricity, a Toronto-based med-tech company is dedicated to developing medical remote monitoring solutions that aid in preventing and managing chronic diseases through the development of medically relevant biometric monitoring solutions for the healthcare and consumer markets. biolife, their product under development, aims to be a lifestyle solution that provides a clear, overall view of one’s health.

Read Moreabout Biotricity Aims Revolutionize Healthcare Sector Innovative Monitoring Solutions

Industrial Internet Security Framework (Radio Segment)

Peggy talks about a recently published “Industrial Internet Security Framework” from the Industrial Internet Consortium, and encourage listeners to take a look at the framework. She speaks to Waqaas Al-Siddiq, co-founder and CEO, Biotricity, about the paradigm shift that the healthcare industry is facing and she explains that this is all part of a bigger movement to move the Internet of Things forward. She says it is all about building a stronger community.

Read Moreabout Industrial Internet Security Framework Radio Segment

Clustering of Five Health-Related Behaviors for Chronic Disease Prevention Among Adults, United States, 2013

Five key health-related behaviors for chronic disease prevention are never smoking, getting regular physical activity, consuming no alcohol or only moderate amounts, maintaining a normal body weight, and obtaining daily sufficient sleep. This study estimates the clustering of these 5 health-related behaviors among adults aged 21 years or older in each state and the District of Columbia and to assess geographic variation in clustering. The results are insightful and fascinating.

Read Moreabout Clustering Five Health Related Behaviors Chronic Disease Prevention Among Adults United States 2013

Why Patients Don’t Adhere to Doctors’ Orders

Outcomes in chronic disease management are directly affected by patients taking the medications and making the lifestyle changes that doctors prescribe. Studies show that even among patients who have health plans with no cost sharing for medications, rates of nonadherence were nearly 40%, so the issue is not simply the high cost of prescription medications. It is people’s “learned helplessness” and their human nature, the force of long-standing habits, which leads them to nonadherence…. Continued

Read Moreabout Patients Dont Adhere Doctors Orders

Biotricity Finalizes Partnership Expansion with the University of Calgary

Biotricity has finalized its long-term research partnership with the University of Calgary. The vision of this expanded partnership is to apply Biotricity’s technology in a variety of areas that lend themselves to remote monitoring. Working with clinical leaders in a number of clinical settings, such as peri-operative medicine, fetal medicine and acute and chronic care medicine, Biotricity will develop prototype remote monitoring mobile devices in order to facilitate the application of “smart” medical grade wearables to the hospital and out-patient settings, and drive the innovation and development into new and never before thought of areas.

Read Moreabout Biotricity Finalizes Partnership Expansion University Calgary

Why Women With Heart Disease Get a Raw Deal in Medicine

Cardiovascular diseases represent the main cause of death in the world. Yet, compared with men, women suffering heart attacks are less likely to get treated on time, and their chances of being diagnosed correctly, and receiving beneficial medication and advice, are much lower. A US study published in 2016 shows that, compared to men, women are less likely to receive potentially beneficial medications such as aspirin and cholesterol-lowering drugs, or to get advice about quitting smoking.

Read Moreabout Women Heart Disease Get Raw Deal Medicine

Biotricity Receives a FDA 510(k) Clearance – Marks Major Milestone in Path to Commercialization

Biotricity has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a key component of its solution. This clearance is another watershed moment in the company’s quest to market its remote cardiac monitoring solution comprised of the Bioflux software and device. Biotricity’s mission is to develop multiple solutions for a variety of chronic illnesses by designing monitoring devices paired with chronic care management tools. Upon commercial availability, the device will be used by physicians and hospitals in the diagnostic process and then by patients for long-term care management.

Read Moreabout Biotricity Receives Fda 510k Clearance Marks Major Milestone Path Commercialization

Solving the Healthcare Crisis with Mobile Big Data Analytics

For years, the healthcare system in the United States has struggled to answer one simple question which is arguably at the root of all of its extravagant costs, failing healthcare objectives, and seemingly interminable patient issues: “How do we get individuals to engage and manage their conditions better?” Personalizing care management by democratizing access to patient data. This requires a confluence of data-driven technologies centered on big data including cloud computing, mobile applications, and real-time analytics of constantly generated data.

Read Moreabout Solving Healthcare Crisis Mobile Big Data Analytics

Helping Physicians Find Valuable Data with Medical Wearables

With electronic health records (EHR) at an approximate 80% usage rate, there’s plenty of data floating around for healthcare providers. In fact, many physicians say they are deluged with a constant onslaught of information. They don’t have enough time to find critical data buried in non-essential details. Add the fact that some EHRs allow a wearable’s data to be uploaded directly into the patient’s medical record and you’ve taken an overloaded data system and added exponential issues for healthcare providers…. Continued

Read Moreabout Physicians Find Valuable Data Medical Wearables

Mobile Cardiac Telemetry (Radio Segment)

Waqaas Al-Siddiq, cofounder and CEO, Biotricity, says physicians are burdened because there are too many patients, and not enough practitioners. He continues that physicians are inundated with information. He explains mobile cardiac telemetry (MCT) is created to deal with risky patients. The doctor wants more data from these patients, and an intelligent device can respond.

Read Moreabout Mobile Cardiac Telemetry Radio Segment

Innovation in Healthcare (Radio Segment)

Waqaas Al-Siddiq, cofounder and CEO, Biotricity, says we are at a precipice where the healthcare industry has to shift to survive, and the connected aspect of it is what is going to drive innovation and response. He explains some of the hurdles in healthcare are reimbursement, and the economics around it, and the regulatory component of it.

Read Moreabout Innovation Healthcare Radio Segment

The Diagnosis: Investors, Corporate Execs, and Regulators Sound Off On Medical Device Innovation

From wearables to portable diagnostics, 9 leaders in healthcare describe opportunities and challenges in the medical device industry. A variety of investors, corporate leaders, and clinicians, ranging from Silicon Valley-based VCs to New York pathologists give their perspectives on medical device trends. Biotricity’s CEO comments on the new connected healthcare industry.

Read Moreabout Diagnosis Investors Corporate Execs Regulators Sound Off Medical Device Innovation

Tech Tuesday: Biotricity May Improve Medical Information

A new partnership between Biotricity, a medical diagnostic and consumer healthcare tech company, and AT&T means that the service provider is now responsible for granting “near real-time connectivity for [Biotricity devices’] data transmission.” Biotricity’s goal is to create an Internet of Things-enabled wearable device. The first such connected device will make its debut at year’s end in the form of the Bioflux solution, Biotricity’s flagship product.

Read Moreabout Tech Tuesday Biotricity May Improve Medical Information

As Tech Trickles in, Medicine is About to Hit Warp Speed

In 2006, nobody had a smartphone in their pocket. Now, people are walking around with sensor-studded, Internet-connected computers more or less attached to their bodies. So, what will medicine look like in the near future? This incredible abundance of apps, sensors, and information has already kicked off a major shift away from traditional medical practices. “Basically, what we’re seeing is the digitization of human beings,” says Dr. Eric Topol. “All these new tools give you the ability to basically quantify and digitize the medical essence of each human being.”

Read Moreabout Tech Trickles Medicine Hit Warp Speed

How the IoT is enabling the next generation of medical devices

Internet of Things (IoT) connected medical devices are a new generation of medical devices capable of transmitting data on an ongoing basis and providing patients and physicians with real-time feedback. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how these devices could enact a preventive healthcare system and facilitate better remote home care, ultimately improving patient outcomes and reducing healthcare costs.

Read Moreabout Iot Enabling Next Generation Medical Devices

World Heart Day Promotes Awareness of World’s Biggest Killer

Cardiovascular disease – heart conditions and stroke – still kills around one in four of us, and takes the lives of more than 100 people in the UK every day. Many of those who survive a heart attack or stroke suffer from a decline in their quality of life through disability and their life expectancy is reduced. Three quarters of cardiovascular disease is preventable. There are big gains to be made through health education and raising awareness of the risks. This means empowering people to make healthy choices related to physical inactivity, smoking, high blood pressure, elevated cholesterol and obesity that reduce the risk of cardiovascular disease.

Read Moreabout World Heart Day Promotes Awareness Worlds Biggest Killer

Biotricity Expands Partnership with the University of Calgary and Expects FDA Response Within Weeks

Biotricity announced that it will be expanding its existing research partnership with the University of Calgary. In order to develop and validate the next generation of medically relevant wearable monitors, the focus of the new partnership will be on areas beyond cardiac medicine including fetal monitoring and sleep apnea. As well, Biotricity is expecting a response from the FDA to their 510(k) submission within the next few weeks.

Read Moreabout Biotricity Expands Partnership University Calgary Expects Fda Response Within Weeks

Bioflux Device Monitors Heart Rhythm and Sends in Real Time to 24 Hour Monitoring Lab

MedicalResearch.com interviews Biotricity’s CEO and President, Waqaas Al-Siddiq. The interview touches on the topic of intelligent remote patient monitoring and how their products Bioflux and Biolife, which provide diagnostic and post-diagnostic solutions for chronic illnesses, will change the traditional healthcare landscape.

Read Moreabout Bioflux Device Monitors Heart Rhythm Sends Real Time 24 Hour Monitoring Lab

Pink, Blue — And IoT?

IoT technology has saved consumers both time and money over the years, but can it now potentially assist in saving babies’ lives? The September edition of The Internet of Things Tracker™ features an interview with Jake Colvin, cofounder of Owlet Baby Care, on how the company’s IoT-powered sock tracks an infant’s vital signs and alerts caregivers when something seems awry.

Read Moreabout Pink Blue Iot

Biotricity’s CEO Interviewed at the 5th Annual Liolios Gateway Conference

Waqaas Al-Siddiq, Co-founder and CEO of Biotricity, gave a brief overview of the company’s outlook, competitive advantage, metrics, opportunity and innovative approach towards the current chronic care market.

Read Moreabout Biotricitys Ceo Interviewed 5th Annual Liolios Gateway Conference

Future Market Trends for Wearable Devices

Waqaas Al-Siddiq discusses the future of device design, new therapeutic applications, how the Internet of Things (IoT) will enhance the usability and effectiveness of wearables, consumer and patient confusion related to data overload, and what role the FDA and other regulatory bodies may play moving forward.

Read Moreabout Future Market Trends Wearable Devices

Daily Digital Prompts Fight Chronic Disease

If taking care of our health is as simple as eating better and walking, why are the statistics surrounding chronic illness worse now than they were 10 years ago? We know that improving our diets and exercise regimens, quitting smoking, and managing stress are powerful steps toward combatting diabetes, heart disease, hypertension and stroke, to name just a few of the top chronic diseases. Yet, we mostly live in denial. Maybe if we had a paradigm shift where we received information on a regular, daily basis about our vital signs we could grasp the gravity of our situations and make more of an effort to take action… Continued

Read Moreabout Daily Digital Prompts Fight Chronic Disease

Wearable Concerns: Lifestyle vs. Medical-Grade Devices

There has been a rise in the number of non-healthcare companies entering the healthcare wearables market. Apple, Google, Samsung, and even Walmart are poised to become large players. Therein lies a potentially scary proposition — consumer electronics manufacturers’ convergence with healthcare providers. Al-Siddiq says, “If you really want to have an impact on healthcare, you need medically relevant devices.”

Read Moreabout Wearable Concerns Lifestyle Vs Medical Grade Devices

Why IoT might prove to be the missing link in chronic disease management

Patient non-adherence is a key issue in chronic disease management, costing the U.S. healthcare system between $100 to $289 billion a year. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how medical wearable devices connected through the internet of things (IoT) incorporate relevant, clinical grade data that could help healthcare providers understand and diagnose their patients’ conditions. Real-time data and feedback could also help physicians determine if patients are adhering to medical directives and encourage non-adherent patients to actively engage in managing their health.

Read Moreabout Iot Missing Link Chronic Disease Management

New Wearable Devices in the Medical and Diagnostic Sectors

A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual’s vital signs. The report explores the different types of devices that can be used as wearable medical devices, and the different types of data that can be monitored by them.

Read Moreabout New Wearable Devices Medical Diagnostic Sectors

Medical Wearables to Help UK’s Ageing Population

Smart wearable monitors and implants can help the NHS cope with increasing demand from an ageing population and improve the patient experience. Around the world people are living longer. On the face of it, rising life expectancy sounds like pretty good news, but in fact it’s set to stretch healthcare systems beyond breaking point.

Read Moreabout Medical Wearables Help Uks Ageing Population

Wearables are a Good Fit for Healthcare

Medically relevant wearable technology can relieve the overstretched NHS while engaging patients in their healthcare and promoting preventive medicine. Healthcare systems are facing a crisis. Chronic illnesses combined with an ageing population and rising healthcare costs are rapidly increasing the burden on the NHS. The pressure will continue to rise because 23 per cent of the UK’s population will be aged over 65 by 2039.

Read Moreabout Wearables Good Fit Healthcare

Wearables in Healthcare Roundup

We’re living in transitional times. Conventional healthcare, as we know it, is changing. Chronic illnesses are affecting masses at an even younger age, and our healthcare system is buckling under the pressure. We need to provide people that have long-term illnesses tangible tools so that they’re realistically able to adopt healthy lifestyle habits daily. We need to push preventative treatment modalities in mainstream healthcare… Continued

Read Moreabout Wearable Healthcare Roundup

Biotricity to Present at the 5th Annual Liolios Gateway Conference on September 8, 2016

Biotricity has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel in San Francisco. Waqaas Al-Siddiq, Co-Founder and CEO of Biotricity will present on Thursday—a live webcast which will be available for replay.

Read Moreabout Biotricity Present 5th Annual Liolios Gateway Conference September 8 2016

mHealth Bridges the Gap from the ICU to the IoT

Biotricity, the Silicon Valley-based developer of the Bioflux mobile cardiac telemetry solution, is eyeing the Internet of Things in its partnership with AT&T. The company is looking to the telecom giant to provide “near-real-time connectivity for data transmission” is it looks to market a clinical-grade platform to the remote patient monitoring market.

Read Moreabout Mhealth Bridges Gap Icu Iot

Enabling clinical-grade health management devices

The healthcare sphere is facing a dichotomy of sorts wherein the individual’s increased consciousness to prioritize health is at odds with his or her lack of time and/or willingness to seek professional opinion and treatment. While a large majority of individuals are seeking to proactively self-manage their health, they are turning to incomplete and inaccurate information gleaned from the Web and from lifestyle and fitness wearables, placing their health in jeopardy. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how next generation clinical-grade wearables could help supply accurate, medically relevant data to improve chronic disease management.

Read Moreabout Enabling Clinical Grade Health Management Devices

AT&T Hooks up Biotricity for Medical Device Data Work

Biotricity has selected AT&T as its preferred network partner, providing the wireless carrier entry into the medical market. AT&T has a pilot program in place that provides Biotricity with “near real-time connectivity for data transmission.” That will expand to a full program later this year, when Biotricity launches its first wearable.

Read Moreabout Att Hooks Up Biotricity For Medical Device Data Work

AT&T to Provide Connectivity for Biotricity Remote Monitoring Solutions

AT&T has become the preferred network partner for Biotricity’s biometric remote monitoring solutions, the healthcare technology provider has announced. At present, AT&T is supporting a pilot of the solution. The development will see the telecommunications giant supporting Biotricity’s wearable medical devices with near real-time connectivity for data transmission.

Read Moreabout Att To Provide Connectivity For Biotricity Remote Monitoring Solutions

Why Don’t Doctors Recognize Cardiac Arrest?

If your heart stops beating, you’re more likely to survive in a casino or airplane than in a hospital. Your hearts stop beating, and you lose consciousness in seconds. If standing, you fall. If sitting, you slump over. Your bodies jerk, and reflexively, you gasp. Those breaths are deceptive. They can trick physicians and nurses into thinking you’re experiencing a seizure, not cardiac arrest. And that misinterpretation can delay resuscitation.

Read Moreabout Why Dont Doctors Recognize Cardiac Arrest

More and More Women Are Now Dying in Childbirth, But Only in America

Chronic conditions such as heart disease and diabetes are causing an alarming increase in pregnancy deaths in the US. In other countries, maternal death rates have fallen sharply since 1990. In South Korea, the rate of women dying in childbirth fell from 20.7 deaths per 100,000 live births to 12 today. In Germany, it dropped from 18 to 6.5. But in the United States, the opposite is happening.

Read Moreabout More And More Women Are Now Dying In Childbirth But Only In America

Battling Chronic Disease with Artificial Intelligence and Predictive Analytics

By now, most practices and hospitals use EHRs if for no other reason than to meet mandated requirements to receive reimbursements under the Affordable Care Act. Treating chronic diseases are costing us billions, and we can do much more than just meet basic mandates. Artificial intelligence and predictive analytics can combine to offer better healthcare for long-lasting illnesses… Continued

Read Moreabout Battling Chronic Disease Artificial Intelligence Predictive Analytics

Wearables, Apps won’t Face FDA Scrutiny

General wellness apps and devices won’t face tough FDA scrutiny, as long as they only promote general wellness and present a low risk to the safety of those who use them. In final guidance on the tools, the Food and Drug Administration says the Center for Devices and Radiological Health “does not intend to examine low-risk general wellness products.” Those products include wearables, apps, video games and software programs.

Read Moreabout Wearables Apps Wont Face Fda Scrutiny

HealthTech: Combining Human and Digital Experience

Virtual healthcare will combine human and digital experience by converting as much of the in-person doctor visit into a remote/virtual one. Future systems will solve the need for providing clinical data.

Read Moreabout Healthtech Combining Human And Digital Experience

Biotricity Selects AT&T to Provide Network Connectivity for its Remote Monitoring Solutions

Biotricity Inc. (OTCQB: BTCY) has selected AT&T, Inc. as its preferred network partner for providing connectivity to the company’s medical devices. AT&T, which is currently providing a pilot of the solution, will power Biotricity’s wearable medical devices with near real-time connectivity for data transmission which supports the company’s vision of creating a true Internet of Things (IoT) enabled wearable medical device.

Read Moreabout Biotricity Selects Att To Provide Network Connectivity For Its Remote Monitoring Solutions

Milliseconds Make the Difference with Heart Rate Variability

Measuring heart rate is nothing new. Doctors have been using monitoring devices for years to measure heart rate and arrhythmias in patients. However, detecting a problem before it occurs almost seems like something out of a futuristic movie. Yet that is exactly what Rockyview General Hospital in Calgary is doing right now in its ICU as it studies heart rate variability (HRV) — the time in milliseconds between two heartbeats… Continued

Read Moreabout Milliseconds Heart Rate Variability

Engaging Patients with Wearable Technology

It’s a wonderful thing that the healthcare industry is almost at an 80% adoption rate of EHRs. In the past 20 years, doctors have gone from being unwilling to give up their paper charts to now typing on laptops or tablets in the exam room. We are finally at a point where the conversation can turn its focus from adoption and turn to the real reason all of this exists: the patient… Continued

Read Moreabout Engaging Patients Wearable Technology

Biotricity to Demonstrate its IoT Medical Device at AT&T’s Shape

Biotricity Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, will demonstrate its revolutionary IoT-connected medical device at Shape, at AT&T Tech Expo being held on July 15–16, 2016 at AT&T Park in San Francisco, CA.

Read Moreabout Biotricity To Demonstrate Its Iot Medical Device At Atts Shape

Biotricity Files for FDA 510(k)

Biotricity Inc. (BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a 510(k) with the U.S. Food and Drug Administration (FDA). Biotricity expects to receive a response from the FDA on its 510(k) submission by early Fall.

Read Moreabout Biotricity Files For Fda 510k

Harnessing Big Data for Healthcare

Healthcare providers have always relied on data to make decisions, from feeling a pulse to taking a PET scan of the brain. Information today offers huge potential to advance healthcare. Bigger data sets mean better accuracy. With remote monitoring, we can access real-time updates which can mean the difference between life and death for patients with chronic conditions such as heart disease or diabetes. Yet providers are literally buried in data… Continued

Read Moreabout Harnessing Big Data Healthcare

Digital Health Hires and Departures: Blueprint Health, Scanadu, Constant Therapy, Zenefits

Biotricity, a company developing medically relevant biometric remote monitoring devices, named Thomas Nelson and J. Bernard Rice to its new board of advisors. Nelson is the former chief operating officer at AARP and Rice is a technology and finance authority. The other advisors are John Rother and Dr. Danny Sands.

Read Moreabout 801

Is Wearable Technology Set to Disrupt Healthcare?

According to Medical Daily, wearable technology was predicted to be the top fitness trend of 2016. But is wearable technology just a trend or does it have the potential to transform the medical industry? Are doctors the next sector to experience a major disruption at the hands of tech?

Read Moreabout Is Wearable Technology Set To Disrupt Healthcare

Medically Relevant Wearables Visionary Biotricity to Present at Wearable Technologies Conference 2016 USA

Biotricity Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, will present a comprehensive presentation at the Wearable Technologies Conference 2016 USA on July 12-13, 2016 in San Francisco, CA.

Read Moreabout Medical Wearables At 2016 Wearable Technologies Conference

Wearable Devices in the Medical Sector

A recent report by Frost & Sullivan indicates that the global healthcare wearable devices market earned $5.1 billion in revenues in 2015 and is estimated to reach $18.9 billion in 2020. The report suggests that new technology will drive demand especially in the sector of chronic disease management and monitoring. Some companies are focusing on this area, including Biotricity, through developing better patient monitoring solutions for physicians and consumers.

Read Moreabout Wearable Devices In The Medical Sector

Biotricity appoints Thomas C. Nelson and Bernard Rice to its Board of Advisors

Biotricity Inc. (OTCQB: BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed Thomas Nelson and J. Bernard Rice to its newly formed Board of Advisors (BOA).

Read Moreabout Biotricity Adds Two Members To Its Board Of Advisors

Thriving in a value-based care model

Transitioning from the fee-for-service reimbursement system to one based on value creates huge financial challenges for health systems. Providers must deliver better outcomes for less money to thrive and figure out a way to improve revenue streams. Lower hospital readmits and Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores drive Medicare reimbursements, fueling the need for hospitals and physicians alike to improve outcomes and revenues… Continued

Read Moreabout Thriving Value Based Care Model

Biotricity to Present at LD Micro Invitational Investor Conference on June 7, 2016

Biotricity’s CEO, Waqaas Al-Siddiq, will present on Tuesday, June 7. The conference will feature 195 companies in the small/micro-cap space and will be attended by influential members of the investment community.

Read Moreabout Biotricity To Present At Ld Micro Invitational Investor Conference On June 7 2016

Delivering on the promise of medical monitoring in wearables

It’s one thing to measure how many steps someone takes in a day to help with fitness goals. It’s quite another to help prevent and manage chronic illnesses. So as the plethora of devices hits the mainstream, it’s important for consumers and healthcare providers alike to understand the differences, what is still needed and what’s yet to be developed … Continued

Read Moreabout Delivering On The Promise Of Medical Monitoring In Wearables

SCN’s Jane King & Biotricity CEO speak with Michael Kramer of Mott Capital

Small Cap Nation’s Jane King & Michael Kramer of Mott Capital speak with Waqaas Al-Siddiq, where Waqaas explains Biotricity’s (BTCY) focus on delivering remote monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic disease and lifestyle improvement.

Read Moreabout Scns Jane King Biotricity Ceo Speak With Michael Kramer Of Mott Capital

Biotricity establishes Board of Advisors

Biotricity welcomes to its Board of Advisors: policy leader and former AARP executive John Rother and healthcare informatics professional Dr. Danny Sands. They will provide strategic advice to the company as it continues to develop its next generation wearable devices.

Read Moreabout Biotricity Establishes Board Of Advisors

Wearables and the heart: using mHealth to detect sickness

Rockyview General Hospital is using a monitor developed by Biotricity to measure heart rate variability (HRV). Whereas most wearable heart rate monitors can measure a patient’s heart rate at intervals, Biotricity’s medical-grade, high-resolution ECG is designed to measure the milliseconds between heart beats.

Read Moreabout Wearables And The Heart Using Mhealth To Detect Sickness

Biotricity appoints medical device expert David Rosa to Board of Directors

Biotricity Inc. (OTCQB: BTCY) has added medical device visionary David Rosa to the company’s board of directors. Rosa has spent the past 25 years in a variety of positions in the medical device industry, and currently serves as a board member on several med technology organizations.

Read Moreabout Biotricity Appoints Medical Device Expert David Rosa To Board Of Directors

Are medical grade devices the next generation of wearables?

Wearable technology continues to grow. According to the International Data Corporation, wearable device shipments will reach 173.4 million units in 2019. At the same time, cardiovascular disease related costs will cost the US healthcare system 1.1 trillion by 2030. Biotricity’s ECG device, Bioflux, provides medical remote monitoring for the diagnostic and post-diagnostic care processes.

Read Moreabout Are Medical Grade Devices The Next Generation Of Wearables

Appoints Norman Betts to Board of Directors

Biotricity has appointed financial professional Norman Betts to the company’s board of directors. An accomplished accountant and professor, Betts also currently serves as a board member for the Bank of Canada, the country’s central bank and the Canadian equivalent to the Federal Reserve.

Read Moreabout Biotricity Appoints Norman Betts To Board Of Directors

Biotricity is filling a gap in consumer healthcare solutions

The statistics surrounding chronic illness in the U.S. are staggering. Heart disease, stroke, and diabetes are three of the most widespread and costly health problems facing our country.

Read Moreabout Biotricity Filling Gap Consumer Healthcare Solutions

5 medical technology innovations you need to know about

In a recent interview with Biotricity (OTCBB:BTCY) CEO Waqaas Al-Siddiq noted that one of the most challenging aspects of medical practitioners is patient compliance. With remote patient monitoring, however, there is a component that can “enable compliance and self-management and the proper feedback.” There are an abundance of monitoring programs that are looking to change the landscape of medical devices, providing health professionals with the ability to monitor their patients remotely and act on a treatment plan.

Read Moreabout 5 Medical Technology Innovations You Need To Know About

Round-up: healthcare provider-related digital health news from Q1 2016

While the quarter saw a lot of use of consumer health technology, at least one survey suggested that clinically-validated tracking technology would improve adoption. In a 1,011-person survey commissioned by The Society for Participatory Medicine and health technology company Biotricity, some 71 percent of US adults said they would use a health tracking device if it was clinically accurate.

Read Moreabout Round Up Healthcare Provider Related Digital Health News From Q1 2016

The Microcap Conference: Notes from the Floor

Biotricity named company to watch at Microcap Conference, an event that provided an opportunity for investors specializing in small stocks to speak with the management of small companies on the market. Although most companies fit exclusively in the tech sector, companies like Biotricity aimed to bridge the gap between technology and healthcare through developing medical device solutions.

Read Moreabout The Microcap Conference Notes From The Floor

What’s holding physicians back from making the wearables leap?

Medical wearables could offer improved patient care and long-term health management, yet physicians are still reluctant to embrace their use. Waqaas Al-Siddiq, Biotricity CEO & Founder, discusses how medical wearables should be interoperable with physicians’ workflow, providing physicians with clinically relevant data at the right time without creating additional burdens on their time.

Read Moreabout Physicians Holding Wearables Back

What’s trending in the IoT space

Our view is that there are five major battlegrounds for IoT and hardware innovation and market growth in the consumer space: connected homes, wearables, healthcare, robotics and drones and transportation. For this article, I’ll cover three sectors (two consumer and one industrial): connected homes, healthcare and industrial IoT.

Read Moreabout Whats Trending Iot Space

Biotricity’s (BTCY) innovative solution to cardiac monitoring

Biotricity has created a cardiac monitoring device called Bioflux that aims to solve a lot of problems for patients and physicians. Unlike holter monitors or event loop recorders, Bioflux is an MCT technology that monitors a patient’s heart rhythm and sends the data in real-time to a 24-hour monitoring lab.

Read Moreabout Biotricitys Btcy Innovative Solution To Cardiac Monitoring

How is IoT changing healthcare?

Although connectivity among medical devices is not new, the Internet of Things (IoT), or the Internet of Medical Things if you will, is gaining traction as the healthcare industry has been increasing efforts to improve quality and the continuum of care. Biotricity, a developer of medical remote monitoring solutions, offers physicians a health IT solution called Bioflux, composed of an electrocardiogram (ECG) monitor, software, and a monitoring lab, that targets cardiovascular disease through diagnostic and post-diagnostic care processes.

Read Moreabout How Is Iot Changing Healthcare

Rockyview General Hospital leverages Biotricity’s remote monitoring technology to track heart rate variability and predict health outcomes

Biotricity Inc. (BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, announced that researchers at Rockyview General Hospital are using the company’s biometric device in a study designed to identify early warning sign for illness and to promote over-all wellness.

Read Moreabout Rockyview General Hospital Leverages Biotricitys Remote Monitoring Technology To Track Heart Rate Variability And Predict Health Outcomes

Biotricity CEO: Why a clear path to revenue is the key to entering new markets

In an age where technology has enabled individuals to — among other things — count calories, track exercise and monitor blood glucose levels, it should not be surprising that companies are using wearable technology to address medical needs. One such company is Biotricity (OTCQB:BTCY), a remote patient monitoring company that’s entered the wearable medical technology market from a cardiac angle.

Read Moreabout 530 2

Scientists hope to uncover link between heart rate and onset of illness

In a North American first, researchers at Rockyview General Hospital are using technology that tracks changes in heart rate to predict health outcomes in patients and indicate overall health and wellness. Heart rate variability is an indicator of stress response in the body and can act as an early warning sign for the onset of illness. Using small portable monitors, the study looks at the effectiveness of monitoring HRV to predict the onset of illness in intensive care unit patients where medical conditions can change quickly.

Read Moreabout Scientists Hope To Uncover Link Between Heart Rate And Onset Of Illness

A crystal ball with a pulse? Uniform heart rate linked to oncoming illness

Dr. David Leipert, the hospital’s director of perioperative medicine, says a lack of variability in a heart rate is an indicator of medical stress… Acting on his hunch, Liepert approached Biotricity, a medical technology firm, and the organization developed a monitor that samples a heart rate 1,000 times in a second.

Read Moreabout A Crystal Ball With A Pulse Uniform Heart Rate Linked To Oncoming Illness

Researchers hope to uncover link between heart rate and onset of illness

Researchers at Rockyview General Hospital are using technology to track a change in heart rate that they hope will predict the onset of illness within the ICU. The study is the first of its kind and project head Dr. Liepert said heart rate variability can indicate stress within the body, so he’s using an ECG on his participants.

Read Moreabout Researchers Hope To Uncover Link Between Heart Rate And Onset Of Illness

Study examines link between heart rate, onset of illness

Dr. Liepert and his team are using a small mobile device developed by the medical technology firm Biotricity (BTCY) that tracks HRV accurately. The small black oval-shaped device – about two by four inches – is attached to the neck or chest of study participants and gathers information only by contacting the skin and does not require electrodes or adhesive patches. 

Read Moreabout 519 2

How insurers and wearables will change healthcare

UnitedHealth Group, the nation’s largest health insurance company, is broadening coverage to pay for wearable devices, fueling an already booming market designed to improve consumer wellness. It’s an emerging trend that could benefit insurers who pay for health wearables as well as the companies making the devices and related technology.

Read Moreabout How Insurers And Wearables Will Change Healthcare

Biotricity to present at the MicroCap Conference Toronto on April 12, 2016

Biotricity Inc., (OTCQB: BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric monitoring solutions, has been invited to present at the MicroCap Conference Toronto being held on April 11–12, 2016 at the Hilton Toronto.

Read Moreabout Biotricity To Present At The Microcap Conference Toronto On April 12 2016

The untapped market for wearables and aging

Aging societies worldwide pose serious challenges to both healthcare delivery and how it is financed. The financial challenges are not only for the healthcare system, but also for families and caregivers who spend a significant amount of time and money caring for elderly. Carers UK, a non-profit organization, has estimated that over 2 million people have given up jobs and over 3 million have cut back hours of work in order to care for sick or disabled elderly relatives.

Read Moreabout The Untapped Market For Wearables And Aging

10 ways that wearable technology can positively change the world

Some wearable tech companies are currently developing remote health monitoring solutions that will enable those in need to avoid spending an exorbitant amount of time and money on in-person monitoring. For example, Biotricity offers advanced Mobile Cardiac Telemetry units that are available for individuals and hospitals. This technology can be used to monitor heart rhythms and respiration, and it also makes it easier for physicians to diagnose medical conditions such as coronary heart disease and cardiovascular disease.

Read Moreabout 10 Ways That Wearable Technology Can Positively Change The World

From IoT to wearables: the 3 technology trends you need to watch in 2016

Though it can be tough to keep up, adapting to technological innovation allows small businesses to gain a competitive advantage in the market place. The three biggest technology trends for 2016 are: biometrics monitoring (wearable technology), the Internet of Things (IoT) and wireless warehouse management.

Read Moreabout Iot Wearables 3 Technology Trends Need Watch 2016

The future of healthcare is self-care and the future is now

The importance of self-care and taking our health back into our own hands is a hot topic these days. Unhealthy lifestyles and the resulting diseases have long-term effects on our bodies – leading practitioners and patients to seek ways to address health issues even before their onset.

Read Moreabout Future Healthcare Self Care Future Now

Three-quarters of patients would use health tracker

As the fitness tracker market is expected to triple by 2019, a recent survey commissioned by The Society for Participatory Medicine and Biotricity indicated that 76% of adults would use a health tracking device if it were user friendly and provided clinically accurate data. Results from the survey also suggested that patients are more engaged and are increasingly willing to work in conjunction with their healthcare providers to self-monitor and manage their health.

Read Moreabout Three Quarters Of Patients Would Use Health Tracker

Survey: 76 percent of U.S. adults would use health tracker if clinically accurate, easy to use

The Society for Participatory Medicine and Biotricity, a health technology company, conducted a survey in December 2015, which found out of the 1,011 U.S. adults that were surveyed, 76% would use a health tracking device if it was clinically accurate and user friendly.

Read Moreabout Survey 76 Percent Of U S Adults Would Use Health Tracker If Clinically Accurate Easy To Use

Biometric monitoring solutions provider, Biotricity, begins trading on the OTC QB Market as "BTCY"

iMedical Innovation Inc., dba Biotricity, a healthcare technology company dedicated to delivering innovative, medically relevant biometric monitoring solutions, has completed a “reverse merger” transaction with Metasolutions Inc. (OTCQB:BTCY)

Read Moreabout Biometric Monitoring Company Biotricity Trading Otc Qb Market Btcy

71% of consumers would use health monitoring devices if data was clinically accurate

71 percent of adults would use a personal health monitoring device if it was clinically accurate, according to a national survey of 1,000 respondents 

Read Moreabout 71 Of Consumers Would Use Health Monitoring Devices If Data Was Clinically Accurate

Consumers want to monitor their health, survey finds

More than eight out of 10 consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, according to a national survey of 1,000 respondents

Read Moreabout Consumers Want To Monitor Their Health Survey Finds

New research finds consumers ready to take active role in managing health & illness

Americans are fully prepared to take a more active role in managing their over-all health and are more than willing to wear personal monitoring devices to help themselves and medical professionals improve their care.

Read Moreabout New Research Finds Consumers Ready Active Role Managing Health

Survey: 71 percent of adults would use a health tracking device if it was clinically accurate

Some 71 percent of US adults said they would use a health tracking device if it was clinically accurate, according to a survey of 1,011 US adults between December 10 and 13th last year. 

Read Moreabout Survey 71 Percent Of Adults Would Use A Health Tracking Device If It Was Clinically Accurate

Wearables market adding to IoT data deluge

The market for wearable devices is fast-emerging with the realization of new market opportunities available across an array of industries. At present, wearables are often limited to traditional markets (i.e. fitness) and rarely cater to multiple functions and applications. By incorporating various functions and applications and addressing current issues related to limited form factors and battery capacity, the potential for market expansion and the creation of new opportunities across industries for wearable devices is an imminent possibility.

Read Moreabout 374 2

How virtual reality will change the health industry

While the interception of healthcare technology and virtual reality is relatively new and underexplored, virtual reality has been used to treat conditions for nearly 20 years. The potential for virtual reality to transform the healthcare industry comes in the form of employee training, facilitation of procedures and improvement of medical methods, leading to increased efficiency and potentially alleviating rising healthcare costs.

Read Moreabout How Virtual Reality Will Change The Health Industry

Why doctors must market themselves in 2016

With advancements in medical technology, doctors will see an increased need to reinvent themselves digitally and use marketing strategies / forms of advertising to secure patients. People are consciously trying to make well informed decisions through doing their own research online. The access to more information however is a double-edged sword and must be seen as a way to supplement traditional doctor-patient interactions.

Read Moreabout Doctors Must Market 2016

An overburdened physician system is yet another obstacle to getting wearables to those who need them

Wearable technology has the strongest potential to deal with chronic illness management and mobility related factors that burden the healthcare system. Although the potential is recognized, doctors struggle with implementing wearables due to lack of training, the inconsistent flow of data, and the lack of a standardized mechanism for entering data from commercial wearables.

Read Moreabout An Overburdened Physician System Is Yet Another Obstacle To Getting Wearables To Those Who Need Them

Doctors don’t know what to do with data from fitness trackers.

More than half the people who own fitness trackers in America have stopped using them. The primary reason is consumers not being able to relate to the tracked data. Doctors too question the benefits of wearable technology because of the use of vague metrics to present meaningless, medically irrelevant data to the clinician who must then extrapolate from non-specific data to find pertinent information.

Read Moreabout Doctors Dont Know What To Do With Data From Fitness Trackers

Biotricity debuts at mHealth Summit

Biotricity is a healthcare technology company dedicated to delivering innovative, medically relevant biometric monitoring solutions that enable people to make lifestyle changes and achieve a better quality of life.

Read Moreabout Biotricity Debuts Mhealth Summit

Your doctor doesn’t want to hear about your fitness tracker data.

Wearable producers such as Apple, Fitbit, and Pebble will ship more than 76 million of the devices by the end of the year, according to market research firm IDC. Some doctors and researchers, however, remain unimpressed. They question the value of the particular metrics tracked, as well as the validity of the deluge of data these gadgets produce.

Read Moreabout Your Doctor Doesnt Want To Hear About Your Fitness Tracker Data

The role of big data in medicine.

In this interview, Dr. Eric Schadt, the founding director of the Icahn Institute for Genomics and Multiscale Biology at New York’s Mount Sinai Health System, tells McKinsey’s Sastry Chilukuri how data-driven approaches to research can help patients, in what ways technology has the potential to transform medicine and the healthcare system, and how the Icahn Institute is building its talent base.

Read Moreabout Role Big Data Medicine

A smart (watch) way of curing stressed doctors.

More than 1,000 doctors and nurses are taking part in a trial to test how stressed they are. Medics in Boston, Massachusetts, will wear smartwatch-style devices which monitor temperature, heart rate and other factors and rank stress on a scale of one to ten.

Read Moreabout A Smart Watch Way Of Curing Stressed Doctors

Providing health services via wearable devices could, finally, become a reality.

Healthcare systems around the world are facing a ‘perfect storm’, contending with rising costs, changing demographics and growing consumer expectations. In a recent report on healthcare in the UK, PA Consulting concluded that a vital component in helping to solve these problems could be the use of ultra-low-power wearable technology.

Read Moreabout Providing Health Services Via Wearable Devices Could Finally Become A Reality

Are wearables fit for clinical trials?

The incorporation of wearable technology devices into clinical trials is attracting attention from both healthcare and life science laboratories, as well as the boardroom. Wearables are already pervasive in the consumer world for fitness and health, and they seem a logical fit in the world of clinical trials.

Read Moreabout Are Wearables Fit For Clinical Trials

Virtual assistance for every brand?

The next wave of wearable devices and the Internet of Things will come not only with many more connected devices — some 50.1 billion in five years — but with specific apps that will provide more complex “virtual assistance”, something every brand will need to consider in their digital marketing plans.

Read Moreabout Virtual Assistance For Every Brand

How can the healthcare sector safely and accurately utilise data from consumer wearables?

A great article in Bioscience Technology acknowledges how new technologies are generating significant amounts of data in the healthcare and life sciences sectors and that this is viewed as a positive development for these markets.

Read Moreabout How Can The Healthcare Sector Safely And Accurately Utilise Data From Consumer Wearables

Engaging patients to decrease costs and improve outcomes.

Increasingly, healthcare providers face insurmountable opposing pressures: To bring down costs, but accomplish more at every patient visit.

Read Moreabout Engaging Patients To Decrease Costs And Improve Outcomes

The strategy that will fix health care.

In health care, the days of business as usual are over. Around the world, every health care system is struggling with rising costs and uneven quality despite the hard work of well-intentioned, well-trained clinicians. Health care leaders and policy makers have tried countless incremental fixes—attacking fraud, reducing errors, enforcing practice guidelines, making patients better “consumers,” implementing electronic medical records—but none have had much impact.

Read Moreabout The Strategy That Will Fix Health Care
[/vc_column_text][/vc_column][/vc_row]